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Although it is known that the prevalence of type 2 diabetes is on the rise in Canada, more 
information is needed on how well type 2 diabetes patients living in Cambridge, Ontario 
self-manage their diabetes and what factors influence their adherence to diabetes 
medication regimens. The objective of this cross-sectional study based on the theory of 
planned behavior was to determine if there are predictors of adherence to diabetes 
medications among patients living with type 2 diabetes in Cambridge. The World Health 
Organization STEPwise Approach to Surveillance was used to collect demographic data. 
Adherence and diabetes knowledge were assessed with the 8-item Morisky Medication 
Adherence Scale and the Michigan Diabetes Knowledge Test, respectively. Research 
subjects were 56 adults recruited through convenience sampling. Predictor variables that 
were tested included age, gender, level of education, and diabetes education, and the 
response variable was adherence to diabetes medication. Level of education (p = .001) 
was the only strong predictor of adherence to diabetes medication in the bivariate logistic 
regression analysis. In addition, in the multivariate logistic regression analysis, the 
following combined variables were significantly associated with adherence to type 2 
diabetes medication: age and level of education; age and diabetes knowledge; gender and 
level of education; gender and diabetes knowledge; and level of education and diabetes 
knowledge. Application of the findings of this study may help to minimize the risk of 
diabetes-associated complications and improve quality of life for those with type 2 
diabetes, thereby reducing type 2 diabetes healthcare costs for patients, insurance payers, 
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Chapter 1: Introduction to the Study 
Diabetes mellitus is a chronic, debilitating medical condition with potentially 
distressing complications. It affects people of all ages and races worldwide. About 30 
million people worldwide were diagnosed with diabetes in 1985; by 2000, that number 
had increased to more than 150 million (Cheng, 2013). The International Diabetes 
Federation (IDF) estimated that in 2014, 387 million people worldwide had diabetes, and 
it is projected that this number will increase to 592 million by 2035 (International 
Diabetes Federation, 2014). Africa and other developing nations are expected to have the 
highest increase in numbers of people diagnosed with diabetes because of poverty and 
poor healthcare facilities (International Diabetes Federation, 2014). Developed nations 
such as Canada are also significantly impacted by the menace of diabetes, which is 
known to be a leading cause of mortality and morbidity (Cheng, 2013). 
The prevalence of diabetes has been increasing dramatically in Canada (Public 
Health Agency of Canada [PHAC], 2011). The city of Cambridge, with a population of 
about 200,000 people is located in the southwestern part of the Canadian province of 
Ontario. There is presently no published information about the factors associated with 
adherence to diabetes management in Cambridge. The approximated prevalence of 
diabetes mellitus in Canada was 6.8% in 2009 (Public Health Agency of Canada, 2011). 
This value indicated an alarming 230% increase when compared to the estimate for 1998 
(Cheng, 2013). Several factors including overweight, obesity, physical inactivity, 
unhealthy eating, tobacco smoking, an aging population and sedentary lifestyle are 
2 
 
commonly linked to diabetes prevalence in Canada (Public Health Agency of Canada, 
2011). It is generally speculated that the incidence and prevalence of diabetes among 
Canadians are much higher than in past decades and these figures are projected to 
continue to increase in the future (Cheng, 2013). In Canada, diabetes is one of the 
principal causes of cardiovascular diseases, blindness, amputation in adults and end-stage 
kidney disease. Diabetes and related complications raise total costs and service demands 
on the healthcare system in Canada. According to Cheng (2013), effective management 
of diabetes would result lower healthcare costs and reduced incidence of diabetes-
associated mortality and morbidity. 
Adherence to prescribed diabetes medication is key to the accomplishment of 
glycemic control and diabetes management goals (Fedrick & Justin-Temu, 2012 ). 
Adherence refers to the committed, noncompulsory, and cooperation of the patient in the 
jointly agreed course of action to produce a curative outcome (Delameter, 2006). Results 
from several studies have suggested that fewer risks of undesirable outcomes are noticed 
when patients take their medications as prescribed (Granger et al., 2005; Horwitz et.al, 
1999; Simpson, Eurich, et al., 2006). Diabetic and cardiac patients who take medication 
according to their physician’s recommendation have a 7% death rate whereas those who 
refuse to follow medical advice have a 12% death rate (Khan, Al-Abdul Lateef, Al 
Aithan, Bu-Khamseen, & Khan, 2012). Nonadherence, in the context of healthcare, refers 
to the degree to which a patient’s behavior (relating to taking medication, adhering to 
lifestyle change directives, completing medical tests, or keeping physician appointments) 
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concurs with a healthcare provider’s health and medical advice (Partridge, Avorn, Wang, 
& Winer, 2002). Nonadherent patients are individuals whose health-seeking or 
maintenance behaviors are not in agreement with a healthcare provider’s 
recommendations (Jin, Sklar, Min Sen Oh, & Chuen Li, 2008). Patient nonadherence is a 
serious issue in healthcare because it hinders successful healthcare delivery and promotes 
negative health outcomes. In almost every country in the world, nonadherence has been 
reported as a serious problem, and in the United States, one-third to one-half of patients 
are nonadherent (Khan et al., 2012). Adherence to prescribed medications is of great 
concern to prescribers, governments, and other stakeholders because of the increasing 
evidence that shows that the refusal of patients to take their medications as prescribed is 
related to higher cost burdens on the healthcare system and preventable adverse outcomes 
(Osterberg & Blaschke, 2005). In Canada, many patients, including those with diabetes, 
show poor adherence to their prescribed medications (Law, Cheng, Dhalla, Heard, & 
Morgan, 2012). Consequently identifying factors that are linked to adherence to diabetes 
management plan may assist in the improvement of diabetes management and prevention 
of diabetes-related complications among diabetes patients in Cambridge. 
Chapter 1 is divided into 12 sections. Literature on the effect of diabetes and 
adherence to diabetes medication regimens is discussed in the introduction and 
background sections. The issue addressed in this study and the intention of this research 
are discussed under the problem statement and the purpose of the study, respectively. The 
research questions and the null and alternative hypotheses are also discussed in this 
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chapter. The study’s theoretical framework is also described, including pertinent 
information related to the theories that informed this study and the relationship of theory 
to this study. The study design and the main reasons for choosing it are discussed under 
the nature of the study. Additionally, I present definitions of terms used in this study, and 
I explain the dependent and independent variables. The assumptions, scope, limitations, 
delimitations, and significance of the study are also discussed in this chapter. 
Background 
Adherence to a diabetes treatment plan is vital to the achievement of the diabetes 
mellitus management goals. Nonadherence to a management regimen is perhaps the main 
reason for preventable undesirable health outcomes among diabetes patients. The rate of 
adherence to the task of taking medication as prescribed varies, yet, have consequences 
on health outcomes and treatment effectiveness (Fedrick & Justin-Temu, 2012). The 
incidence and prevalence of diabetes mellitus are on the rise in Canada and in a number 
of other nations around the world (Public Health Agency of Canada, 2011). The most 
recent comprehensive Canada-wide diabetes prevalence study was conducted between 
2008 and 2009 by the Canadian Chronic Disease Surveillance System (Public Health 
Agency of Canada, 2011). In this study, the diabetes status of Canadians ≥ 1 year old at 
the time of the study was assessed. Results of the research show that the prevalence of 
diabetes in Canada in 2009 was 6.8%. This indicated that about 2.4 million Canadians 
had diabetes in 2009. It is projected that the numbers of Canadians with diabetes will 
increase to about 3.7million by 2019 (Public Health Agency of Canada, 2011). All ages 
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and ethnic groups that make up the Canadian population are affected by diabetes. The 
groups that have a higher risk of developing diabetes include Aboriginal Canadians and 
individuals of Hispanic, Asian, and African descent (Canadian Diabetes Association, 
2011b). Diabetes is among the commonest chronic diseases in Canada, and if not 
effectively managed, it can result in eye disease, nerve damage, erectile problems, heart 
disease, and higher healthcare costs (Canadian Diabetes Association, 2013; Cheng, 
2013). For this reason, it is important for researchers to continue to concentrate on 
investigations that may promote effective management of the disease. 
Management of diabetes generally starts immediately after diagnosis (Canadian 
Diabetes Association, 2013). Effective management of diabetes usually requires a 
coordinated multidisciplinary approach. In Canada, the team of healthcare professionals 
involved with diabetes management includes family physicians, endocrinologists, nurses, 
dietitians, pharmacists, and exercise specialists. All of these health professionals work 
together with the patient to achieve optimal glycemic control (Canadian Diabetes 
Association, 2013; Borgermans, Goderis, & Van Den Broeke, 2009). Diabetic patients 
have to be able to understand, properly follow, and implement clear instructions from 
each of these healthcare providers in order to reach good glycemic control (Ortiz, 
Cabriales, Gonzalez, & Meza, 2010). Expected patient self-care behavior in diabetic care 
plan management usually includes (a) self-monitoring blood glucose (SMBG); (b) using 
prescribed medications as instructed; (c) exercising regularly; (d) following a meal plan; 
and (e) keeping doctor’s appointments (Chatterjee, 2006; Funnell & Anderson, 2004; 
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Poskiparta, Kasila, & Kiuru, 2006; Xu, Pan, & Liu, 2010). Executing these roles or 
behaviors imposes daily demands on the time and comfort of people living with diabetes, 
and successful implementation of these behaviors is mostly dependent on patient 
willingness and competence (AlJasem, Epirot, Wissam, & Rubin, 2001). Patients’ strict 
adherence to diabetes self-care plans plays an important role in improving their quality of 
life; however, complying with diabetic care plans is often difficult for patients and 
represents a big challenge for healthcare professionals. 
One study (Cramer, 2004) involved an extensive systematic review of adherence 
to prescriptions by diabetes patients. The purpose of the study was to estimate the extent 
to which diabetes patients omitted their medications. The author reviewed related 
literature from 1966 to 2003 to identify quantitative data that related to adherence to 
diabetes medications. The investigator was able to identify needed records of adherence 
in several retrospective and prospective studies. Analysis of the retrospective studies 
indicated that adherence to oral hypoglycemia medications was between 36% and 93% in 
patients who had been receiving treatment for six to 24 months. Analysis of prospective 
data showed that adherence was from 67% to 85% of prescribed oral diabetes doses. 
Adherence to insulin prescriptions was noted to vary from 62% to 64% among adults, 
while young individuals suffering from diabetes only filled about 33% of the doses of 
insulin prescribed to them. The researcher concluded that patients with diabetes were 
generally poor adherers to both oral and injectable diabetes medications (Cramer, 2004). 
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Adherence to diabetes medication continues to be a serious healthcare issue in 
various cultures and communities in Canada, including those in Cambridge. Increasing 
the rate of medication adherence among diabetics in Cambridge communities may help to 
reduce the clinical risk associated with diabetes. Investigators have studied adherence to 
diabetes management in various communities and have identified several factors that 
influence adherence to diabetes medication in the communities where the studies were 
conducted. Failure to keep appointments (Rhee et al., 2005), poor health provider-patient 
communication (Ciechanowski, Kato, Russo, & Walker, 2001), taking several different 
pills (Marcum & Gellar, 2012), and low levels of patient education (Peyrot & Rubin, 
1994) have been identified as factors in poor adherence to diabetes medications. 
Additionally, adherence to medication is influenced by religious beliefs and local 
traditions (Collins-McNeil et al., 2012). Review of the literature shows that factors that 
impact adherence may vary from one community to another. For instance, the authors of 
an adherence study conducted in Saudi Arabia claimed that female gender is one of the 
important factors that influence adherence to diabetes treatment plans (Khan et al., 2012). 
In another study conducted in one of the largest diabetes clinics in Ethiopia, the authors 
indicated that gender did not significantly influence diabetes medication adherence 
(Gelaw et al., 2014). In view of the fact that no diabetic adherence study had been 
conducted in Cambridge, I conducted this study to address a gap in the literature. This 
study adds to the existing body of research that relates to adherence to debates medication 
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management regimens by identifying factors that are linked to adherence to diabetes 
management in Cambridge. 
Problem Statement 
The management of chronic diseases, including diabetes, generally involves the 
use of medications for a long period of time. Even though studies have shown the 
beneficial effects of using pharmacotherapy in chronic disease management, its 
usefulness has not been fully appreciated, given that close to 50% of patients with 
chronic diseases do not take their prescriptions as recommended by their healthcare 
practitioners (Brown & Bussell, 2011). 
Despite the fact that medical services are freely available to all Canadians, 
diabetes mellitus remains a very serious medical and public health issue in Canada 
(Canadian Diabetes Association, 2013; Public Health Agency of Canada, 2011). 
Although diabetes is becoming increasingly prevalent in Cambridge, as in Canada as a 
whole, no investigations have been conducted on preventive methods that involve 
diabetes knowledge, awareness of diabetes risks, and lifestyle factors that could help to 
improve adherence to diabetes medications in Cambridge. My review of the literature 
indicated that no adherence studies among individuals with diabetes in Cambridge had 
ever been conducted. Studies evaluating the impact of the combination of predictors of 
adherence are also not available. Moreover, barriers leading to nonadherence to diabetic 
self-management and self-care behaviors were yet to be determined in Cambridge. 
Investigators have noted that educational level, female gender, inconsistency in follow-
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up, noncompliance with prescription medications, noncompliance with prescribed 
exercise regimen, use of injectable insulin with oral metformin, and injectable insulin and 
living in an urban area are important factors linked to adherence to diabetes management 
plans (Khan et al., 2012). Lack of proper understanding of diabetes medication regimen, 
inability to afford some or all prescribed medications, and time lags between visits to 
health workers have also been shown to be associated with adherence to medication 
regimens (Kalyango, Owino, & Nambuya, 2008). However, no research has been 
conducted to determine whether gender, age, socioeconomic status, diabetes knowledge, 
dosing frequency, duration of disease, self-efficacy, and alcohol use are associated with 
adherence to diabetes management in Cambridge. Identifying and comprehending factors 
relating to adherence are important in changing the lifestyle and other characteristics in 
order to support treatment adherence and good health. Consequently, it is important to 
examine factors related to adherence to diabetes medications in Cambridge because such 
knowledge can add to the literature related to diabetes management in Canada and 
beyond. 
Purpose of Research 
The purpose of this cross-sectional quantitative research was to identify and 
evaluate links between age, gender, level of education and diabetes knowledge and 
adherence to diabetes medication among individuals with type 2 diabetes in Cambridge. 
A proper understanding of the effect of independent variables, such as age, gender, level 
of education, diabetes knowledge on adherence to diabetes medication (dependent 
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variable) could assist in the development of more effective nonadherence preventive 
strategies that could reduce the incidence of diabetes complications, reduce diabetes 
management costs, and promote improved quality of life for individuals with diabetes in 
Cambridge. 
Theoretical Framework 
The theory of planned behavior (TPB) developed by Ajzen (1991, 2005) was used 
in this study to provide the framework for a proper understanding of factors and 
dynamics involved in the association between patients’ perceptions, attitudes, and beliefs 
in relation to performing certain behaviors that promote adherence to prescribed diabetic 
treatments (Ajzen, 2001). As Ajzen (2001) explained, “The theory of planned behavior 
indicates that people act in accordance with their intentions and perceptions of control 
over the behavior, while intentions in turn are influenced by attitudes toward the 
behavior, subjective norms, and perceptions of behavioral control” (p. 43). Adhering to 
prescribed medications or management plans involves planned or intended behaviors. For 
instance, when an individual is prescribed one or more medications, some definite or 
specific behaviors are vital for the medication to be beneficial, such as taking the 
prescribed medication as directed(e.g., once daily in the morning, or every 8 or 12 hours 
with or without food). However, it is the duty of the patient to execute the required 
expected behavior and ensure adherence to medications. Individuals that have the 
ultimate goal of controlling their blood sugar or diabetes will routinely adhere to 
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prescribers’ directives of taking their medications and will follow other management 
plans strictly. 
TPB is an offshoot of the theory of reasoned action (TRA; Ajzen & Fishbein, 
1980). TPB is a complete behavioral theory because it provides a basis for predicting 
behavior and adjustments (Casper, 2007). It is assumed in the formulation of TPB that 
people are sensible beings who are capable of making logical judgments. TPB is not 
applicable to motives that are unconscious. TRA holds that the intention to exhibit a 
particular behavior or perform an action can be predicted by subjective norms and 
attitudes. TRA is associated with voluntary behavior; it is related to causal experience of 
intentions to execute behaviors over which individuals have sufficient control (Ajzen, 
2005, p. 117). It was assumed in the development of TRA that individuals have volitional 
control over all of the behavior that they want to perform—that is, individuals are able to 
perform specific behaviors if they want to. However, problems crop up with TRA 
whenever the theory is applied to behaviors that are not completely under volitional 
control (Ajzen, 1991). 
In 1985, Ajzen included a third construct or component of perceived behavior to 
TRA, at which point he renamed the theory as the theory of planned behavior (Ajzen, 
1991, 2005). This third component was added because Ajzen (1991) noted that the 
majority of behaviors humans engage in are not under volitional control. Perceived 
behavioral control refers to a person’s perceptions of his or her ability to execute 
behavior of interest. The inclusion of the component of perceived behavioral control 
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made it possible for TPB to explain the likelihood of partial control of volition (Ajzen, 
1991, 2005). The three components that make up TPB—attitude, perceived behavior, and 
subjective norms—are categorized as higher level theoretical constructs by scientists and 
this theory is designed to help predict and give explanations to human behavior under 
certain circumstances. Behavior is a “function of salient information, or beliefs, relevant 
to the behavior” (Ajzen, 1991, p. 189). Behavior can be planned or deliberate. TPB, as 
depicted in Figure 1, is the most appropriate theoretical framework for this research 
because it can predict deliberate or planned behavior. 
 
Figure 1. Model of the theory of planned behavior. From Ajzen (1991), “The Theory of 
Planned Behavior, ” Organizational Behavior and Human Decision Processes, 50, p. 
182. Copyright 1991 by I. Ajzen. Adapted from public domain with author permission 
 
Nature of Study 
Cross-sectional design is the research design method that is predominately used 
by researchers to investigate various socioeconomic and cognitive areas of adherence to 
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medication regimens. In social science research, this design method is one of the most 
commonly used (Frankfort-Nachmias & Nachmias, 2008). Like several previous 
adherence research studies, this quantitative research study used a cross-sectional design 
to determine the factors that are related to adherence to diabetes medication regimens 
among individuals with type 2 diabetes in Cambridge. 
Three data-gathering instruments were used in this study. Patients’ demographic 
data were collected with the aid of the World Health Organization STEPwise Approach 
to Surveillance (WHO STEPS) demographic instrument, diabetes knowledge was 
assessed with the aid of the Michigan Diabetes Knowledge scale, and medication 
adherence was measured with Morisky Medication Adherence scale. This study 
concentrated on diabetic patients aged 18 years and over who received their prescription 
and nonprescription medications from Metro Pharmacy Limited in Cambridge. Data 
analysis was conducted with the aid of logistic regression analysis, which assisted in 
determining the strength of relationships and the significance of each independent 
variable in terms of adherence to diabetes medication (dependent variable).The objective 
of this investigation was to evaluate predictors of adherence to diabetes medications. As a 
result, I sought to explore the impact of the independent variables—age, gender, level of 
education, and diabetes knowledge—on adherence to diabetes treatment, which was the 




Research Questions and Hypotheses 
The questions below were used to explore the influence of age, gender, level of 
education, and diabetes knowledge on adherence to diabetes management in Cambridge, 
Ontario, Canada. The major research questions involved four independent variables and 
only one dependent variable. Hypotheses based on these questions were tested. 
RQ1: Are the variables age, gender, diabetes knowledge, and level of education 
associated with adherence to diabetes medication among individuals with 
type 2 diabetes in Cambridge? 
Ho1: There is no relationship between age and adherence to diabetes 
medications among individuals with type 2 diabetes in Cambridge. 
Ha1: There is a relationship between age and adherence diabetes medications 
among individuals with type 2 diabetes in Cambridge. 
Ho2: There is no relationship between gender and adherence to diabetes 
medications among individuals with type 2 diabetes in Cambridge. 
Ha2: There is a relationship between gender and adherence to medications 
among individuals with type 2 diabetes in Cambridge. 
H03: There is no relationship between diabetes knowledge and adherence to 




Ha3: There is a relationship between diabetes knowledge and adherence to 
diabetes medications among individuals with type 2 diabetes in 
Cambridge. 
H04: There is no relationship between level of education and adherence to 
diabetes medications among individuals with type 2 diabetes in 
Cambridge. 
Ha4: There is a relationship between level of education and adherence to 
diabetes medications among individuals with type 2 diabetes in 
Cambridge. 
RQ2: Are any pair-wise combinations of the variables age, gender level of 
education and diabetes knowledge linked to adherence to diabetes 
medication among individuals with type 2 diabetes in Cambridge? 
Ho5: The age and gender combination is not significantly linked to adherence to 
diabetes medications among people with type 2 diabetes in Cambridge. 
Ha5: The age and gender combination is significantly linked to adherence to 
type 2 diabetes medication among individuals with diabetes in Cambridge. 
Ho6: The age and level of education combination is not a significantly linked to 




Ha6: The age and level of education combination is significantly linked to 
adherence diabetes medication among individuals with type 2 diabetes in 
Cambridge. 
Ho7: The age and diabetes knowledge combination is not significantly linked to 
adherence to diabetes medication among individuals with type 2 diabetes 
in Cambridge. 
Ha7: The age and diabetes knowledge combination is significantly linked to 
adherence to diabetes medication among individuals with type 2 diabetes 
in Cambridge. 
Ho8: The gender and level of education combination is not significantly linked 
to adherence to diabetes medication among individuals with type 2 
diabetes in Cambridge. 
Ha8: The gender and level of education combination is significantly linked to 
adherence to diabetes medication among individuals with type 2 diabetes 
in Cambridge. 
Ho9: The gender and diabetes knowledge combination is not significantly 
linked to adherence to diabetes medication among individuals with type 2 
diabetes in Cambridge. 
Ha9: The gender and diabetes knowledge combination is not significantly 
linked to adherence to diabetes medication among individuals with type 2 
diabetes in Cambridge. 
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Ho10: The level of education and diabetes knowledge combination is not 
significantly linked to adherence to diabetes medication among individuals 
with type 2 diabetes in Cambridge. 
Ha10: The level of education and diabetes knowledge combination is 
significantly linked to adherence to diabetes medication among individuals 



















Figure 2. Theoretical model for this study. Fully diluted model adapted and modified from I. Ajzen (1991) “The Theory of 
Planned Behavior, ” Organizational Behavior and Human Decision Processes, 50, p. 182. Copyright 1991 by I. Ajzen. Adapted 























































I made the assumption that study participants were volunteers who participated 
willingly and not under any inducement so as not to bias the study. Further, I assumed 
that diabetic patients who participated in this study provided complete and correct 
answers to the survey questions. Last, I assumed that all data-gathering instruments used 
in the study correctly measured the variables that were tested. 
Limitations 
This study was a cross-sectional study that concentrated on the link between the 
factors influencing diabetes medication adherence (independent variables) and adherence 
to a diabetic medication regimen (dependent variable). Because the study was cross-
sectional and involved measurement of association, causation was not explored. I 
hypothesized that age, gender, level of education, and diabetes knowledge would impact 
adherence to medications, and as a result I used bivariate logistic analysis to identify the 
direction of the association between the dependent variable and the independent 
variables. A cross-sectional research design was best for this study because the aim of the 
study was to identify factors that impact diabetes adherence status in Cambridge. The 
results from this investigation were limited to diabetes patients living in Cambridge and 
should not be generalized to diabetic populations that are dissimilar to that in Cambridge. 
Scope and Delimitations 
This investigation was a quantitative study and did not explore the reasons why 
participants in the study behaved in the ways they did. This study concentrated on 
20 
 
adherence to diabetes medication regimens among patients living in Cambridge, and the 
scope of the study did not include other medical conditions such as cardiovascular 
diseases, which are likely linked to dissimilar problems of adherence. Criteria for 
inclusion included diagnosis with diabetes, 18 years of age or older, and residing in 
Cambridge. Criteria for exclusion included prediabetic status, using only a lifestyle 
modification method to control diabetes, and inability to read, write, or understand the 
English language. 
Significance 
Diabetes mellitus has developed into a global epidemic. When not managed 
properly, diabetes can result in complications that may lead to higher healthcare costs and 
poor quality of life (Blackburn, Swidrovich, & Lemstra, 2013). Proper management of 
the disease would lead to better health outcomes and lower healthcare costs. Moreover, a 
good understanding of the roles of age, gender, level of education and diabetes 
knowledge on adherence to diabetes medication can help in the development and use of 
more effective interventions. In that there is presently no research in the literature on 
adherence to diabetes medications among diabetic patients in Cambridge, identifying the 
variables that influence diabetes adherence status for this population is beneficial. Data 
and results from this study contribute to increase the level of useful knowledge possessed 
by diabetes educators, health intervention developers, nurses, family physicians, internal 
medicine specialists, endocrinologists, and other clinicians involved in diabetes 
management who are looking for ways to improve adherence to diabetes management 
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among diabetic patients in Cambridge. Another potential benefit of this research is the 
promotion of social change through the provision of valuable information that helps 
health practitioners to better assist and educate patients on how they can be positively and 
actively involved in their healthcare, especially in the area of adherence to prescribed 
medications. 
Definitions of Terms 
Diabetes mellitus: A chronic illness characterized by inability of the body to 
control blood sugar levels within normal range (CDA, 2013). 
Diabetic patient: A person diagnosed with diabetes and having A1C values 
greater than 7whoreceives treatment from a heath care provider (CDA, 2013). 
Adherence: The degree to which individual patients comply with the directives 
that are provided by healthcare practitioners for the management of their medical 
condition (Bissonnette, 2008). 
Chronic diseases: Noncommunicable illnesses that are continual or persistent in 
nature and are hardly ever treated completely. A person can be affected by a chronic 
illness for a few months or longer. Sometimes, a chronic illness can be due to an inherited 
gene (Canadian Diabetes Association, 2009). 
Socioeconomic status: This status is based on income earned yearly. 
Attitude toward the behavior: Describes an individuals’ disposition to an action 




Perceived behavioral control: Individuals ‘ perception about whether or not they 
possess the ability to carry out or execute a particular behavior (Ajzen, 2001). 
Subjective norm (SN): Perceived pressure from close associates to perform or not 
perform a specific behavior (Ajzen, 2001). 
Self-efficacy: Person’s ability to effect control over issues affecting his or her life 
(Bandura, 1989). In this study, self-efficacy involved prevention of diabetes and 
associated complications. 
Diabetes knowledge: Knowledge acquired during a diabetes education program 
that assists individuals in properly understanding diabetes and how to adequately manage 
the condition (Khunti, Camosso-Stefanovic, Carey, Davies, & Stone, 2008). 
Behavior: According to TPB, behavior is a determinate of a persons’ compatible 
intentions and perceptions of the ability to control or execute a particular action (Ajzen, 
2005; Ajzen &Fishbein, 1980). 
Clinician: A person with the knowledge and authority to diagnose and treat 
illnesses (U.S. Department of Health and Human Services [USDHHS], 2012a). 
Glycemia: The occurrence of glucose in the blood (American Diabetes 
Association [ADA], 2011). 
Glycemic control: HbA1C equal to or less than 7.0% (ADA, 2011; Bartels, 2004). 
Healthcare practitioner: A person who assists with supporting patients’ 
healthcare needs (U.S. Department of Health & Human Services, 2012a). 
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Hemoglobin A1C or A1C test: A test done in a laboratory to measure mean 
glucose control for the last 2 to 3 months (American Association of Clinical 
Endocrinologists [AACE], 2009). 
Summary 
Diabetes and other chronic diseases can be better controlled and managed if 
patients adhere strictly to treatment plans. Investigators have identified that adherence to 
medical therapies by those with chronic diseases including diabetes is generally poor. 
Suboptimal adherence to diabetes treatment contributes to poor glycemic control and 
continues to be the principal impediment to the achievement of diabetes treatment goals. 
As a result, it is important for investigators, policy makers, healthcare providers, and 
other stakeholders to come up with interventions that could bring needed change to 
address this problem. For this research, I evaluated the factors and barriers that influence 
adherence to diabetes medication among individuals living with diabetes in Cambridge. 
In this chapter, literature on diabetes has been briefly highlighted in relation to diabetes 
prevalence, consequences of nonadherence to diabetes medication, benefits of adherence, 
diabetes management methods, and appropriate strategies that can assist in identifying 
factors that influence adherence to diabetes treatment. Although there are several 
treatment options for diabetes management and control in Cambridge, Ontario, a gap in 
knowledge indicates a lack of information about the factors that promote adherence or 
nonadherence to available diabetes treatment options. This study fills a gap in the 
literature by evaluating factors that influence adherence to diabetic medications among 
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diabetes patients in Cambridge, Ontario. This research adds to the existing body of 
research by evaluating the role of sociodemographic characteristic and medication side 
effects on adherence to diabetes medication in Cambridge. 
In Chapter 2, I review important literature pertaining to this study. Chapter 3 
contains in-depth descriptions of the research design, study method, study participant 
selection procedures, and measures for ethical protection of interested individuals. In 
Chapter 4, I present and discuss the results of the study, and I explain how I arrived at my 
findings. Chapter 5 includes interpretation of the study results, conclusions, and 




Chapter 2: Literature Review 
There is growing concern about the increasing prevalence of diabetes throughout 
Canada, including in Ontario, where Cambridge, the site of this study, is located 
(Canadian Diabetes Association, 2009; Cheng, 2013; Public Health Agency of Canada, 
2011). Ontario is known to have a much higher numbers of individuals diagnosed with 
diabetes when compared with most other provinces in Canada (Public Health Agency of 
Canada, 2011). PHAC (2011) reported that among the Canadian provinces, Ontario has 
the third-highest number of individuals diagnosed with diabetes. Diabetes self-
management behaviors such as proper nutrition, adequate physical activity, medication 
adherence, blood sugar monitoring, and proper foot care are vital to good quality of life 
and prevention of diabetes-related complications (Chatterjee, 2006; Poskiparta et al., 
2006; Xu et al., 2010). Nonetheless, individuals with diabetes generally fail to adhere to 
diabetes self-management practices (Blackburn et al., 2013; Nelson, Chapko, Reiber & 
Boyko, 2005; Xu et al., 2010). Investigators have shown that diabetes patients are less 
likely than nondiabetic patients to adhere to diabetes medications (Hertz, Unger, & 
Lustik, 2005), unlikely to adhere to dietary guidelines (Chowdhury, Helman, & 
Greenhalgh, 2000; Nelson, Reiber, & Boyko, 2002), less likely to engage in physical 
activity at prescribed levels (Nelson, Reiber, et al., 2002), and unlikely to engage in self-
monitoring of blood sugar as recommended (Karter, Ferrara, Darbinian, Ackerson, & 
Selby, 2000). Additionally, they tend to disregard recommendations regarding foot care 
(Safford, Russell, Suh, Roman, & Pogach, 2005). Given that no adherence studies 
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involving diabetes have been conducted in Cambridge, it is important to explore the 
factors that influence diabetes management behaviors among individuals with diabetes in 
Cambridge. Insight can be gained from the identification of factors related to diabetes 
medication adherence in Cambridge. 
In this chapter, current literature relevant to my research area is comprehensively 
reviewed. Topics addressed in this literature include studies of diabetes mellitus, diabetes 
management regimens including oral and injectable diabetes medications, adherence to 
diabetes therapies, factors that influence diabetes adherence status, and TPB. Several 
researchers have reported that investigators have concentrated more on physical activity 
adherence than on adherence to oral antihyperglycemic medications in individuals with 
diabetes (Blanchard et al., 2008; Calitri, Lowe, Eves, & Bennett, 2009; Plotnikoff, 
Lippke, Courneya, Birkett, & Sigal, 2010). This research adds to existing knowledge by 
concentrating on adherence to oral diabetes medication regimens. Additionally, this study 
included an in-depth review of intentions, attitude, perceived control, subjective norms 
and the association of these components to oral diabetes medication regimens. Peer-
reviewed journals constituted the majority of journals consulted for this study. 
Organization of the Review 
This literature review section is arranged into themes (indicated by subtitles) in 
order to present comprehensive discussion and exploration of important issues that 
influence diabetes management plans and adherence to diabetes treatment regimens. The 
literature review begins with a comprehensive review of books, articles and other sources 
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of information relevant to my study methodology, followed by a review of information 
related to the research tools. Next, I present literature that relates to diabetes, adherence 
statues, and factors that influence adherence. Various methods of diabetes management 
are discussed. In addition, I present information related to TPB, which served as the 
foundation for this study. 
Literature Search Methodology 
The bulk of the material I consulted for the literature review consisted of peer-
reviewed articles. The majority of the journals included were primary studies. However, 
secondary information sources such as meta-analyses, governmental research, and books 
were included to make my research more robust and comprehensive. I used the Walden 
University Library to search for and obtain useful articles from the MEDLINE, 
PsycARTICLES, PsycINFO, and CINAHL databases. Other databases that I used 
included PubMed, SAGE Full-Text collection, Cochrane Library, Health and Medical 
Complete, and OVID. Articles were also retrieved from Google Scholar and useful 
websites such as those of World Health Organization, American Diabetes Association 
(ADA), Centers for Disease Control and Prevention (CDC) , American Medical 
Association (AMA), and American Public Health Association(APHA). The websites of 
the Public Health Agency Canada (PHAC) and the Canadian Diabetes Association 
(CDA) provided statistical information. 
Keywords that were employed to search for relevant literature included diabetes, 
type 1 diabetes, type 2 diabetes, diabetes prevalence, hypoglycemia, hyperglycemia, 
28 
 
adherence, nonadherence, compliance, diabetes medications, hypoglycemic medications, 
diabetes related complications, attitude, intensive diabetes management, and theory of 
planned behavior. Most of the literature used for this study was published between 2004 
and 2014. However, useful older articles were also included. Keyword searches yielded 
40 full-text articles from PsycINFO, 50 full-text articles from CINAHL, and 310 full-text 
articles from MEDLINE. In addition, I obtained 1,320 references from Google Scholar. 
This literature review created the foundation for establishing the significance of this 
research and served as a gauge or standard to compare the findings of this investigation 
with those of earlier studies that have explored adherence to diabetic medication 
regimens. 
Theoretical Framework 
I used the theory of planned behavior (TPB) as my theoretical framework for this 
research. This theory provides a basis for exploring behavioral modification, behavior 
prediction, and psychological processes (Ajzen, 1991; Casper, 2007). 
Description of the Theory 
TPB, like other psychological theories and models, is based on assumptions. The 
main assumptions of TPB are that attitudes, perceived behavioral control and subjective 
norms (SNs) are the main determinants of intentions (Ajzen, 1991, 2005). Additionally, 
TPB presumes that the degree of intention under consideration partly determines the 
relative significance of attitude about an expected behavior, as well as perceived 
behavioral control and subjective norm (Ajzen, 2005). In addition, TPB presumes that 
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perceived behavioral control has stimulus effects for intentions (Ajzen, 2005, p. 119). 
The aim of this research is to encourage diabetic patients to adhere to their diabetic 
medication regimens and other management plans. 
The principles of aggregation and cognitive self-regulation form a significant 
portion of TPB (Ajzen, 1991). The important proposition that underscores the principle of 
aggregation is the fact that certain behaviors are influenced not only by general 
disposition, but also by several related factors that are associated with certain or expected 
behaviors (Ajzen, 1991, p. 180). However, the principle of aggregation does not predict 
exact behavior under a specific circumstance. Behavioral intentions refer to multiple 
factors that are associated with certain behaviors (Ajzen, 1991, 2005). As a result, the 
central principle of TPB is the intention to execute a particular behavior or action. 
Intentions refer to the power that an individual can exercise in order to achieve certain 
behavioral objectives. In addition, intentions can be described as the value of probability 
that a person will carry out a particular behavior (Ajzen & Fishbein, 1980, p. 42). 
Intentions encompass those important factors that control behaviors, which include 
knowledge, income, gender, ethnicity, race, education, experience, religion, media 
exposure and religion. These factors are known to also impact adherence to diabetic 
medication regimens and management plans (Ajzen, 2005). The more powerful an 
associated intention is, the better probability there is that an individual will perform an 
intended behavior (Ajzen, 1991). Nonetheless, the intended behavior must originate from 
a voluntary decision of the individual (Ajzen, 1991, p. 181; Ajzen, 2005, p. 99); the 
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implication of this is that the individual may decide to perform or not perform the 
behavior. 
Furthermore, it is worthy of note that intentions are subject to time. The shorter 
the time taken to measure a particular behavioral intention, the greater the probability of 
getting accurate results and vice versa (Ajzen, 1991, 2005; Ajzen & Fishbein, 1980). 
Investigators have been able to accurately measure over a short period of time behaviors 
that causes minor problems from attitude and intentions (Ajzen, 1991). ). Over time, 
people’s intentions and attitudes can change; thus, measurement of intentions and 
attitudes over a long period of time may not accurately predict behavior (Ajzen, 1991). 
Adhering to diabetic medication is a behavior that creates no harm to the patient; as a 
result, perceived control, intention and attitude can accurately predict adherence to 
diabetic management regimen among diabetic patients in Cambridge. 
Constructs of the Theory of Planned Behavior 
The combination of attitude in respect to a certain behavior, perception of 
behavioral control, and subjective norms result in the production of behavioral intention 
(Ajzen, 1991). The TPB consist of four constructs (see Figure 1). According to 
Ajzen(1991, 2005), intentions are assumed to be a function of attitude concerning a 
behavior (an individual’s overall assessment of ability to execute a behavior), subjective 
norms (reflection or belief about the expectations of other important people), and 
perceived behavioral control (belief regarding the presence of factors that may help or 
hinder the effecting of the behavior). The constructs of intentions, subjective norms, 
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attitude, and perceived behavioral control form the bedrock of TPB. The more 
enthusiastic an individual’s attitude and subjective norms, and the greater the perceived 
control, the stronger the individual’s intention will be to carry out the expected behavior. 
Intention is an important construct of TPB. This theory involves an assumption that 
attitudes toward an expected behavior play a more decisive role for some intentions than 
for others, for which subjective norms are more important in helping to predict the 
intended behavior (Ajzen, 2005). In some behaviors, one or two of the constructs may be 
behavioral intention determinants, whereas in others, all of the constructs—subjective 
norms, attitude, and perceived behavioral control—are important in determining 
behavioral intention (Ajzen, 2005). TPB does not involve the extent of control that a 
person exerts to perform a particular behavior, but it deals with the influence of perceived 
behavioral control on the performance of the behavior (Ajzen, 2005). TPB involves an 
assumption that attitude controls behavior mainly through intentions (Ajzen, 2005). 
Nevertheless, numerous studies have shown that attitude at times directly controls 
behavior (Bentler & Speckart, 1979; Zuckerman & Reis, 1978). 
Empirical Studies That Support the Theory of Planned Behavior 
TPB is a valuable theory for predicting health-protective behavior. In a study 
testing the predictive value of TPB, McCaul, Sandgren, O’Neill, and Hinsz (1993) 
recruited 219 subjects for a project that was expected to promote adherence to health-
protective behaviors (dental hygiene and detection of cancer).The results of the study 
showed that intention to engage in action that will lead to cancer detection and teeth 
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flossing is predicted by subjective norms and attitudes. It was also noted that perceived 
control more significantly added to the prediction of intention to perform the health-
protective behaviors when compared to self-efficacy. The results from this study support 
other studies that show that TPB can predict health-protective behavior (McCaul et al., 
1993). 
Several other studies have shown strong evidence that intentions to carry out 
certain behavior can be predicted by attitude, perceived behavioral control and SNs 
(Ajzen, 1991, 2005). A review of the literature shows that from 1986 to 1991, 16 studies 
were conducted to determine whether it is possible to predict an individual’s intention 
from attitude, perceived behavior control, and subjective norms (Ajzen, 1991). In all 16 
studies, investigators identified a strong correlation that was in the range of 0.43 to 0.94 
(Ajzen, 1991), and 0.71 was found to be the mean multiple regression for all of the 
studies (Ajzen, 1991), thus showing that TPB has high validity and reliability in 
behavioral intention predictions. 
Kopelowicz et al. (2007) studied adherence to medication regimen individuals 
with schizophrenia using TPB. The results showed test-retest coefficients of .88 for 
attitude, .91 for subjective norms, and .86 for perceived behavioral control. 
Consequently, TPB can be regarded as a valid and reliable model for measuring and 
identifying factors promoting adherence to medication regimen among diabetic patients 
residing in Cambridge, Ontario, Canada. TPB has been used in several studies to predict 
diabetes patients’ adherence to physical activity recommendations, and in many of these 
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studies, investigators have observed a strong association of intention and attitude 
(Blanchard et al., 2008; Calitri et al., 2009; Keats, Culos-Reed, Courneya, & McBride, 
2007; Plotnikoff et al., 2010). However, review of the literature indicates that fewer 
studies have been conducted in the area of adherence to oral and injectable diabetic 
medications. As a result, this study adds to current research by determining the factors 
that promote adherence to diabetic management in Cambridge. 
A study conducted by O’Neill et al. (2008) employed the TPB theoretical 
framework to predict adherence to mammogram appointments. The results of the study 
showed that the TPB model was able to accurately predict the intention of patients in 
honoring their appointments within the next nine months (O’Neill et al., 2008). 
Correspondingly, this study adds to current research by determining the factors that 
promote adherence to diabetic management in Cambridge 
The Meaning of Diabetes Mellitus 
Diabetes is a common chronic disease that results either when the beta cells of the 
pancreas do not produce sufficient insulin or when the insulin produced by the pancreas 
is not effectively use by the body (Goldenberg & Punthakee, 2013). Insulin is the 
hormone that helps the body control blood sugar. Inside the body cells, sugar is 
metabolized to produce the energy that people require to live. If sugar is unable to get 
into the cells due to inadequate insulin or inability to effectively utilize available insulin, 
sugar increases to detrimental levels in the blood (Goldenberg & Punthakee, 2013). After 
some time, high levels of blood sugar may fatally compromise virtually all of the organs 
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in the body, potentially resulting in strokes, heart attacks, kidney failure nerve damage, 
impotence, blindness, and infections that result in amputations (Goldenberg & Punthakee, 
2013; Levitan, Song, Ford, & Liu, 2004). 
There are three main types of diabetes: type 1, type 2, and gestational (American 
Diabetes Association, 2012; Goldenberg & Punthakee, 2013). Individuals with type 1 
diabetes mellitus normally are unable to produce their own insulin and as a result need 
insulin injections to stay alive. Individuals with type 2 diabetes typically are able to 
produce insulin but cannot do so adequately or are unable to effectively utilize available 
insulin (American Diabetes Association, 2012; Goldenberg & Punthakee, 2013). 
Individuals with type 2 diabetes are generally overweight (World Health Organization, 
2015). The prevalence of type 1 diabetes complications is much higher compared to type 
2 complications (Dall, Mann, et al., 2009). Type 2 diabetes can be prevented or delayed 
by maintaining a normal body weight, eating a healthy diet, observing regular physical 
activities and keeping away from smoking (World Health Organization, 2011). Although 
type 2 diabetes is preventable, it has a substantial economic burden on the healthcare 
system, given that about 90% of individuals with diabetes have type 2 diabetes (Dall, 
Zhang, et al., 2010). Gestational diabetes is the glucose intolerance that is diagnosed 
during pregnancy (American Diabetes Association, 2012; Goldenberg & Punthakee, 
2013). 
In 2012, an estimated 1.5 million deaths worldwide were directly linked to 
diabetes (World Health Organization, 2014). Worldwide diabetes prevalence (defined as 
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a fasting plasma glucose value ≥7.0 mmol/L [126 mg/dl] or taking diabetes medication 
for elevated blood glucose) in 2014 was about 9% among individuals that were aged 18 
years and over (World Health Organization, 2014). It is projected that, by 2030, diabetes 
may become the seventh leading cause of death worldwide (Mathers & Loncar, 
2006).The lowest diabetes prevalence is noted in low-income nations, whereas the 
highest diabetes prevalence is noted in upper- to middle-income nations (World Health 
Organization, 2014). 
Diabetes is among the most common chronic medical conditions that affect 
Canadians. The CDA (2011) estimated that about 2.7 million Canadian had diabetes in 
2010; this translates to a prevalence of 7.6%. The actual number may be higher, given 
that many people living with diabetes are undiagnosed for several years (Public Health 
Agency of Canada, 2011). The high level of diabetes prevalence in Canada is a concern, 
and the CDA (2011) has projected that by 2020, 10% of the Canadian population will be 
diabetic. 
Significance of Glycemic Control 
Achieving or maintaining optimal glycemic target is very crucial in diabetes 
management (Imran, Rabasa-Lhort, & Ross, 2013). Many individuals living with diabetes 
find it hard to achieve glycemic control or recommended glycemic levels because their 
glucose levels are not regularly or correctly monitored by them and their healthcare 
providers. The most important challenge of diabetes management is how best to 
accomplish glycemic control (Berard, Blumer, Houlden, Miller, & Woo, 2013). The two 
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important methods of assessing glycemic control include glycosylated hemoglobin (AIC) 
testing and patient self monitoring of blood glucose (Berard et al., 2013; Canadian 
Diabetes Association, 2013). Maintaining and achieving a healthy glycemic target (A1C 
≤7%) helps to reduce the risk of microvascular and macrovascular complications (Imran 
et al., 2013). 
Glycosylated Hemoglobin Testing (A1C) 
The glycosylated hemoglobin test result indicates what an individual’s mean 
blood glucose level had been in the last three to four months prior to the test (Canadian 
Diabetes Association, 2013; Imran et al., 2013; McCarter, Hempe, & Chalew, 2006). 
This is a helpful way of determining how well an individual’s blood sugar levels have 
been controlled over the last three to four months. The A1C test can be conducted at any 
time during the day, and results are not affected by exercise, diet, and stress. An A1C test 
result is a reliable indicator of diabetes complication and effectiveness of treatment 
(Berard et al., 2013). A1C is also a reliable test for diabetes diagnosis and a useful tool 
for continuous monitoring of blood sugar in diabetes care (Canadian Diabetes 
Association, 2013). CDA guidelines for the prevention and management of diabetes in 
Canada recommend that for people with diabetes, an A1C test should be conducted every 
three months when glycemic control or target is not achieved and when medication is 
being adjusted. And also that this test should be conducted once every six months when 
lifestyle and treatment are stable, and target has been consistent (Berard et al., 2013; 
Canadian Diabetes Association, 2013). It is imperative to ensure that blood sugar level is 
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under tight control, this means ensuring that blood glycemia is as close as possible to 
normal (nondiabetic). For an individual to have tight control, fasting blood glucose levels 
should between 4 to 7mmol/l and a postprandial plasma glucose levels of 5 to 10 mmol/l 
two hours after meals while A1C should be equal or less than 7% (Imran et al., 2013). 
Tight blood glucose control is crucial for the prevention of diabetes-related microvascular 
complications. There is persuasive proof from several randomized controlled trials that 
improved blood glucose control decreases the risk of diabetes-related microvascular 
complications but however have no major consequence on macrovascular outcomes in 
individuals recently diagnosed with type 1 and type 2 diabetes as well as in patients that 
have been living with type 2 diabetes for a long period of time (Imran et al., 2013). 
Results from United Kingdom Prospective Diabetes Study (UKPDS) on type 2 diabetes 
(Stratton et al., 2000) and the Diabetes Control and Complications Trial (DCCT) on type 
1 diabetes (The Diabetes Control and Complications Trial Research Group, 1995) 
indicate a continuous association between A1C and diabetes-related complications. In the 
UKPDS trial, a 1.0% reduction in A1C was related to up to 37% reduction in the risk of 
diabetes-associated microvascular complications, about 14% decline in myocardial 
infarction and about 21% lower rate of deaths from diabetes (Stratton et al., 2000). 
Meanwhile a decrease of 10% in A1C in the DCCT study was related to between 40 to 
50% decline in the risk of progression of retinopathy (The Diabetes Control and 
Complications Trial Research Group, 1995). Researchers are of the opinion that most of 
the diabetes-related complication could be avoided by assisting patient to move from very 
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poorly controlled diabetes to fairly or well controlled diabetes and also that reduction of 
A1C to 6% from 7% will also further reduce the risk of microvascular complications 
(Canadian Diabetes Association, 2013). In addition A1C reduction has been associated 
with reduction in the cost of managing diabetes (Gilmer et al., 2005). One study uses data 
from a Minnesota health plan to investigate the impact of AIC, Cardiovascular disease 
and depression on healthcare cost among those living with diabetes. The analysis of three 
years data shows clearly that there is a relative increase in cost of managing diabetes 
patient for every 1% rise in A1C level. These costs were noted to be even higher in 
diabetes patients with heart diseases (Gilmer et al., 2005). 
Self Blood Glucose Management (SMBG) 
SBGM is another important blood glucose monitoring tool that is commonly used 
for monitoring glycemia or blood glucose level (Berard, 2013). It plays a vital role in 
diabetes management especially in diabetes self care and treatment (Karter, Parker, & 
Moffet, 2006). Benefits of SBGM include: 
1. It is the only available blood glucose testing method that can help a diabetic 
patient confirm and correctly treat hypoglycemia. 
2. It can help patients know if their lifestyle modification and therapeutic 
treatment is yielding expected results. 
3. It can also provide vital result to both clinicians and patients to aid in short or 
long-term modification and treatment decisions in individuals with type 1 or 
type 2 diabetes (Karter, Parker, et al., 2006). 
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Results from a study with a random sample of 6989 individuals with type 2 
diabetes showed that participants that perform SMBG test were noted to have a lower 
A1C numbers (8.1 +/- 1.6) when compared to the control group that had a higher AIC 
level (8.4+/-1.45, P 0= .012). This result indicates that a better glycemic control is 
associated with SBGM (Guerci et al., 2003). Data from a large cohort study indicated that 
for individual with type 1 diabetes, performing SMBG three or more times a day resulted 
in 1.0% decline in A1C (Consensus Committee of American Diabetes Association et al., 
2007). Also a nonrandomized trial shown that performing SGBM for at least three times 
daily resulted in better glycemic control in type 2 diabetic patients that are on insulin 
(Sheppard, Bending, & Huber, 2005). The number of times that SMBG must be 
performed is individualized according to each patient’s particular need. Factors that 
normally determine the numbers of times a patient should perform SBGM include nature 
of therapy; satisfactoriness of blood glucose control; education and ability to read 
numbers; potential for hypoglycemia; knowledge about hypoglycemia; nature of job; and 
acute illness (Berard et al., 2013). In a survey conducted in United Kingdom to gauge the 
views of type 2 diabetes patients on the benefits of SMBG in diabetes management. 
Investigators specifically asked study participants to indicate the benefits that they derive 
from SMBG and specify how they were able to achieve them. Results from the survey 
showed that 80% of the study participants reported that they were highly satisfied with 
SMBG and they also reported that they feel more in control of their disease (Barnard, 
Young, & Waugh, 2010). In spite of the benefits from SMBG, many individuals are very 
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uninterested in self-monitoring their glucose levels because of a few obvious problems 
associated with SMBG. Some of these problems include pain at injection site, patient 
denials of their condition, discouragement, high cost of blood glucose test meter and 
strips (Barnard et al., 2010). A longitudinal research conducted with 18 type 2 diabetes 
patients to determine patients perspectives on performing SMBG over time, shows that 
diabetic patients reduces their frequency of performing SMBG with time because of lack 
of encouragement from their healthcare providers, decline in interest for self-monitoring, 
difficulties in interpreting meter readings, lack of adequate knowledge on how to respond 
appropriately to meter reading were some of the identified reasons why some patient are 
unable to take full advantage of the benefits of SMBG (Peel, Douglas, & Lawton, 2007). 
SMBG have been shown to be most beneficial when implemented alongside with 
educational program that promotes behavioral changes such as lifestyle changes with or 
without hypoglycemic agents in response to changes in blood glucose results (Polonsky, 
Fisher, & Schikman, 2011). Diabetes education programs also teach patient the right 
methods of performing blood glucose test, recording test, interpreting blood sugar 
readings and how to make informed decision (Canadian Diabetes Association, 2013). 
Failure to perform SMBG as recommended could lead to wrong adjustment of 
medication dosage, nutrition modification and physical activities that are crucial for the 




The A1C and the fasting blood glucose (FBG) tests are used in Canada for type 2 
diabetes screening (Ekoé, Punthakee, Ranson, Prebtani, & Goldenberg, 2013). Unlike 
many other chronic diseases, the method for diagnosis and screening for diabetes are the 
same for diabetes. However, the A1C test is not a recommended diabetes diagnostic test 
for children, people with advanced liver or kidney disease, those with type 1 diabetes, 
patients that are older than 65 years and in individuals with abnormal hemoglobin 
(Goldenberg & Punthakee, 2013). Diabetes screening means testing for diabetes in 
people that are not aware that they have diabetes. Screening for type 1 is not generally 
recommended because unlike type 2 diabetes, there are presently no proven interventions 
to delay its onset or prevent the disease (Canadian Diabetes Association, 2013; Ekoé et 
al., 2013). The percentage of adults with undiagnosed type 2 diabetes could be greater 
than 10% in some populations (Rathmann et al., 2000; Rolka et al., 2003). Apart from 
helping to diagnose and identify individuals with diabetes, screening assist healthcare 
practitioners to identify individuals that are at a low or high risk of becoming diabetic 
(Cowie et al., 2002; Knip et al., 2010). In a study conducted in Canada to investigate the 
prevalence of undiagnosed diabetes and sugar intolerance, 9042 individuals of 40 years 
and over were recruited for the investigation. Patients with causal prink glucose reading 
greater than 5.5 mmol/l were asked to do the FBG. And if the FBG test result was 6.1–6.9 
mmol/l, a 2hPG in a 75 g OGTT test was ordered. Results from these various tests were 
used to allocate patients into the different diagnostic groups. The data from this study 
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show that 2.2% of participants had undiagnosed diabetes, Glucose intolerance were 
identified in 3.5% of study participants and 16.4% of participant were previously known 
to be diabetic. The finding of this study support and justify routine screening for diabetes 
in individual that are ≥ 40 years old every three years in Canada (Leiter et al., 2001). 
Diabetes Risk Factors 
Presently, all the risk factors that are responsible for the development of type 1 
diabetes are not fully known (Canadian Diabetes Association, 2013; Public Health 
Agency of Canada, 2013). Nevertheless, investigators agreed that interaction between 
environmental factors and acquired genes are responsible (Beyhan & Leslie, 2008; Public 
Health Agency of Canada, 2011). Obesity is commonly regarded as the most important 
risk factor responsible for the increasing incidence of type 2 diabetes (Hramiak, Leiter, 
Paul, & Ur, 2007; Morrison & Chanoine, 2007). Apart from being the most important 
risk factor for the increasing rate of diabetes, obesity is also a risk factor in several other 
chronic diseases such as cancers, breathing disorders, Heart diseases, arthritis, sleep and 
depression (Hramiak et.al, 2007; Morrison & Chanoine, 2007). The numbers of 
individuals that are obese in Canada is on the increase (Shields et al., 2010). According to 
Wing (2000), 80% to 90% of patients with type 2 diabetes are either obese or overweight. 
Also obesity is noted to be prevalent in people with type 1 diabetes (Conway et al., 
2010).One study has shown that about one-quarter of Canadians are obese (Shields et.al, 
2010). In a study conducted to determine the trend of obesity in Canada, investigators 
calculated Body mass index (BMI) for individual who are ≥ 18 years old that were not 
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residence in a long-term care. Investigators utilized information from Canadian health 
surveys conducted between 1985 and 2011. The results of the study were categorized into 
the following classes of weight: normal (BMI 18.5–24.9), overweight (25.0–29.9), obese 
class I (30.0–34.9), obese class II (35.0–39.9) and obese class III (≥ 40.0). The 
investigators used outcome measurement to determine prevalence of adult obesity based 
on weight categories. They estimated future adult obesity with the aid of regression 
analysis. Their findings show that adult obesity prevalence climbed from 6.1% in 1985 to 
18.3% in 2011. The investigators also noted an increase in obesity prevalence in classes 1 
to 111 weight categories between 1985 and 2011. The authors projected that by 2019, 
about half of Canadian provinces will have more obese and overweight adults than those 
with normal weight (Twells, Gregory, Reddigan, & Midodzi, 2014). Obese adults are up 
to four times more likely to develop type 2 diabetes than individuals who are not obese 
(Public Health Agency of Canada, 2011). In a systematic review and meta-analysis 
research conducted in Canada to determine the incidence of comorbidity associated with 
overweight and obesity, the authors did an in-depth literature search for several 
comorbidity associated with obesity and overweight in Canada with the aid of Medlin 
and Embase search engines. They extracted 89 studies that met their inclusion criteria 
(prospective cohort studies that have adequate sample size and report estimates that are 
based on the disease incidence). The researcher identified 18 different comorbidities that 
were associated with obesity and satisfied the study comorbidity inclusion criteria. The 
results of the meta-analysis show a significant statistical relationship between overweight 
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and the incidence of the following: type 2 diabetes, all types of cardiovascular diseases 
(with exception of congestive heart failure), gallbladder disease, chronic back pain, 
osteoarthritis, asthma, and all cases of cancer (with the exception of prostate cancer in 
males and esophageal cancer in females). The strongest relationship was noticed between 
overweight and the incidence of type 2 diabetes in females (RR3= .92 (95% Cl: 3.10-
4.97). In addition, the results of this study also show that there is a significant statistical 
relationship between obesity and the incidence of the following: type 2 diabetes, all 
cardiovascular diseases (with exception of congestive heart failure), gallbladder disease, 
chronic back pain, osteoarthritis, asthma, and all cases of cancer (with the exception of 
prostate cancer in males and esophageal cancer in females).Obesity was also noted to be 
strongly related with type 2 diabetes incidence in females (12.24 (9.03-17.06)) (Guh et 
al., 2009). The study concluded that obesity and overweight are related to the incidence 
of several chronic diseases including type 2 diabetes. Apart from overweight and obesity, 
other diabetes risk factors in Canada include lifestyle, environmental, economic, genetic 
and social factor. Also important are physical inactivity, ethnicity, old age, pregnancy, 
and family history, smoking and residing in rural area (Public Health Agency of Canada, 
2011). 
Complications of Diabetes Mellitus 
In spite of the multidiscipline approaches implemented to manage diabetes 
mellitus, the illness can still lead to several types of complications (Public Health Agency 
of Canada, 2011) The short-term complications associated with diabetes includes; 
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diabetic ketoacidosis (Public Health Agency of Canada, 2011); slow healing of bruises 
and cuts (Argenta & Morykwas, 2004); recurrent bladder and skin infections (Argenta & 
Morykwas, 2004). These short-term complications can lead to life threatening situation if 
not quickly managed (Public Health Agency of Canada, 2011). Diabetes is known to 
increase the potential of developing cardiovascular disease in diabetic individuals — a 
condition that include heart disease, stroke, and peripheral vascular disease (Public 
Health Agency of Canada, 2011). People with diabetes are two to four times more likely 
to have cardiovascular disease compared to people without (Booth, Kapral, Fung, & Tu, 
2006). Cardiovascular diseases are the principal cause of death in people with type 2 
diabetes and also the main reason for the high healthcare for Canadians living with 
diabetes (Simpson, Corabian, Jacobs, & Johnson, 2003). Mental disorders, including 
major depressive disorder, eating disorders and generalized anxiety disorder, are more 
common in individual with diabetes when compared to people without diabetes. 
Individual with psychiatric disorder and diabetes have reduced medication compliance, 
decrease adherence to planned diabetes self-care, higher levels of functional impairment 
(Canadian Diabetes Association, 2013). Apart from cardiovascular diseases and mental 
disorders, other long-term complications associated with diabetes include diabetic 
retinopathy, which results in damage to retinal blood vessel and thus can lead to loss of 
vision or impairment (Canadian Diabetes Association, 2013, Public Health Agency of 
Canada, 2011; Wong & Klein, 2008); diabetic nephropathy, which results from damage 
to kidney blood vessels by high blood sugar, potentially resulting in kidney failure 
46 
 
(Canadian Diabetes Association, 2013; Lok, Oliver, Rothwell, & Hux, 2004; Public 
Health Agency of Canada, 2011); and nerve damage, resulting from damage to the blood 
vessels by high blood glucose levels, which then leads to low blood flow to the nerves 
and subsequent nerve damage. Damage to nerves causes numbness, tingling pain, delayed 
gastric emptying, foot ulceration, foot amputation, and erectile dysfunction (Public 
Health Agency of Canada, 2011); gingivitis and periodontitis, two of the common dental 
conditions associated with diabetes patients (Lamster, Lalla, Borgnakke, & Taylor, 
2008); congenital malformations (Allen et al., 2007); and lung diseases, including 
asthma, pulmonary fibrosis, pneumonia, and chronic obstructive disease (Ehrlich, 
Quesenberery, Van Den Eeden, Shan, & Ferrara, 2010). 
Diabetes in Canada 
There are more than 20 individuals diagnosed of diabetes every hour in Canada 
(Canadian Diabetes Association, 2009). The rising prevalence of diabetes is noted almost 
in every province in Canada including in Ontario where the city of Cambridge is located 
(Public Health Agency of Canada, 2011). Lipscombe & Hux (2007) conducted a study in 
Ontario to determine trends in mortality and prevalence of diabetes from 1995 to 2005 
and diabetes incidence from 1997 to 2003 in individuals that are ≥ 20 years old. The 
investigators used population-based data, in addition to valid diabetes databases obtained 
from the province of Ontario. The results show that prevalence of diabetes climbed from 
5.2% in 1995 to 8.8% in 2005. Prevalence was also noted to rise from 6.9% in 2000 to 
8.8% in 2005. Prevalence rate was noted to be consistently higher in individuals ≥50 
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years old (7.1% of 3,675,554) when compared to people in the age range of 20 to 49 
years old (3.5% of 5,601,391).The younger population shows the greatest increase in rate 
of diabetes occurrence (94% vs 63%, p < 0.0001). The incidence of occurrence increased 
to 8.2 per 1000 in 2003 from 6.6 per 1000 in 1997, showing that over a period of six 
years, there was a yearly 31% increase in incidence of occurrence of diabetes. Also, from 
1995 to 2005, mortality rate was noted to fall by 25% in individuals with diabetes 
(Lipscombe & Hux, 2007). The results of a study conducted to ascertain diabetes 
prevalence in Canada in 2004 by Canadian primary care sentinel surveillance network put 
diabetes prevalence in Canada as 7.2%. In this study investigators analyzed medical 
records of 272,469 diabetic patients. Participants were 10 years and older and had visited 
a primary healthcare provider within the last two years before the study. The results also 
show that patient with diabetes see their healthcare providers about 1.42 times more 
compared to those individuals who are not diabetic (95% CI 1.42 to 1.43, ) and also that 
patient with diabetes have 1.29 more of other medical conditions compare with 
individuals that are not diabetic (95% CI 1.27 to 1.31, p less than 0.0001) (Greiver et al., 
2014). 
The observed total direct and indirect cost for diabetes management in Canada in 
2010 was $11.7 billion. This cost is projected to increase to $16 billion by 2020. This 
increasing cost is threat to Canada’s future economic prosperity and healthcare system 
sustainability (Canadian Diabetes Association, 2011). 
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The direct cost includes cost for treatment, care, rehabilitation, hospitalization, 
institutional care, primary care (family physicians and specialist) and medications. 
Indirect cost includes economic cost related to loss as result of illness, injury associated 
disability and premature death (Canadian Diabetes Association, 2009). Although the 
numbers of Canadian with diabetes is huge, it is estimated that about 700,000 individuals 
with diabetes do not know that they have diabetes (Canadian Diabetes Association, 
2009).The medical cost incurred on individual with diabetes is three times more than on 
people without diabetes (Canadian Diabetes Association, 2009). The estimated direct cost 
for medications and diabetes supplies for managing an individual with diabetes could cost 
from $1,000 to $15,000 annually (Canadian Diabetes Association, 2009). 
Diabetes Management 
Diabetes is a chronic illness requiring self-care. Effective diabetes self- 
management is vital to optimal control of blood sugar levels and prevention of diabetes 
complications (Canadian Diabetes Association, 2013; Watkins & Connell, 2004). 
Adherence to diabetes self-care behavior prevents the development of complications. 
Diabetes self-care behavior includes; adequate nutrition, physical activities, foot care, self 
blood glucose monitoring and medications adherence (Chatterjee, 2006; Poskiparta et al., 
2006; Xu et al., 2010). The risk of diabetes complications decreases by about 43% by 
doing recommended physical activities, eating a proper diet, and maintaining the right 
weight (Lindström et al., 2006). Despite all the benefits that are obtainable from diabetes 
self-care managements, a significant percentage of diabetes patients fail to adhere 
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diabetes self-management plan (Jordan & Jordan, 2010). Statistical analysis for the year 
2000—the Behavioral Risk Factor Surveillance System (BRFSS) data of 11,674 diabetes 
patients—shows that only about 50% of the patients tested their blood glucose levels as 
recommended (Nelson, Reiber, et al., 2002).One Finnish study reported that up to 19% of 
diabetes patient failed to engage in diabetes self-care behavior (Toljamo & Hentimen, 
2001). 
Diabetes and Physical Activities 
Physical activity or exercise is an important integral in diabetes management. 
Studies have shown that physical activities assist individuals with diabetes to achieve the 
following; better glycemic control, reduced insulin resistance, sustained weight loss, 
increased strength, better blood pressure control and decrease need for diabetes 
medications (Chudyk & Petrella, 2011; Sigal et al., 2013). Resistance exercise 
complemented with regular aerobic exercise has been shown to significantly reduce A1C 
in addition to reducing body fat (Church, Blair, & Cocreham, 2010; Sigal et al., 2013). 
Current Canadian diabetes management guidelines recommend that individuals with 
diabetes should involve in aerobic exercise of moderate to vigorous intensity for up to 
150 minutes each week, (Sigal et al., 2013). In addition to aerobic exercise diabetes 
patients are advised by the guideline to engage in resistance exercise at least twice every 
week (Sigal et al., 2013). The guideline recommended that physical activities or exercise 
should be supervised by experts because meta-analysis of trials that evaluated the benefits 
of physical activities reported that supervised exercises were more effective and showed 
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more beneficial effect on A1C, body resistance to insulin and weight than exercises with 
less supervision (Gordon, Benson, Bird, & Fraser, 2009). 
Despite the fact that engaging in physical activity is beneficial for patients with 
diabetes, many diabetic patients still do not engage adequately in physical activities. 
Nelson, Reiber, et al. (2002) reported that in the United States only about 31% of patients 
with type diabetes engage in regular physical exercise and also that 38% of patient with 
type 2 diabetes indicated that they engage in less than recommended physical activities. 
Also another study indicated that only about 37.7% of diabetic patients engage in regular 
exercise (Safford et al., 2005). Patients indicated that that they find it difficult to adhere 
to prescribed physical activities because of the following reasons; fear of low blood 
glucose (Dubé, Valois, Prud’homme, Weisnagel, & Lavoie, 2006), risk of high blood 
pressure (Sigal et al., 2003), poor health, poor eyesight, falling/stumbling, and fear of 
been attacked by criminals (Belza et al., 2004). 
Pharmacotherapy 
Adherence to prescribed medication is a key factor that determines good 
therapeutic outcomes in diabetes patients (Fedrick & Justin-Temu, 2012; McGibbon, 
Richardson, Hernandez, & Dornan, 2013; Sweileh et al., 2004). Results from several 
studies have suggested that fewer risks of undesirable outcomes are noticed when patients 
take their medications as prescribed (Granger et al., 2005; Horwitz et.al, 1990; Simpson, 
Eurich, et al., 2006). In spite of great innovation and tremendous advancement in the 
diagnosis and management of diabetes, most diabetes patients still fail to adhere to 
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prescribe diabetes treatments (Fedrick & Justin-Temu, 2012; Sweileh et al., 2004). Data 
from a retrospective cohort research that investigated adherence to pharmacotherapy 
therapy by type 2 diabetes patients shows that 37% of patients stopped taking their 
medications about 12 months after their first diabetes medications, about 10.5% refused 
to refill their medications after their first diabetes prescriptions and approximately 46.2% 
of the participants were nonadherent to their medications (Hartz et al., 2006). Insulin 
regimens (Basal-bolus) are the main therapeutic agent use for the management of with 
type 1 diabetes. Insulin regimens are normally administered several times during day and 
in some cases the insulin is infused continuously through the subcutaneous (McGibbon et 
al., 2013). For patients to benefit maximally from insulin therapy there is the need to 
tailor regimen to patient’s treatment goals, way of life, eating habit, health status, 
enthusiasm, knowledge about hypoglycemia and self-management capability (McGibbon 
et al., 2013). Treatment or management of type 2 diabetes are generally individualized 
because most patient with type 2 diabetes have different needs and each of them have to 
be treated according to their needs and severity of their diabetes. Individuals with type 2 
diabetes experience a gradual decrease in the amount of insulin produced by the beta cells 
of the pancreas as the disease progresses, and as result management must be dynamic to 
accommodate this gradual decline in insulin (Harper et al., 2013). Medications used for 
managing diabetes are varied and as result the following important factors are important 
to be considered when choosing hypoglycemic agents; patients ability to comply with 
medication regiment, medication side effects, medication efficacy especially ability to 
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reduce diabetes complications, presence of other medical conditions, potential of 
medication to cause hypoglycemia (Harper, 2013). The CDA has a published consensus 
guideline for the management of hyperglycemia in patients with type 2 diabetes. 
According to the guideline, management begins with lifestyle modification (which 
includes physical activity and nutritional therapy) with or without drug therapy. If 
glycemic control or target is not achieved at two to three months of lifestyle intervention, 
suitable therapy such as metformin is either included or increased in order to attain target 
(Harper et al., 2013). And if, after three to six months of inclusion of metformin, target is 
still not achieved, another agent that best suits the patient is added to the medication 
regimen. Adjustment to and or addition to medication regimen continues until target is 
achieved (Harper et al., 2013). The guideline recommended that if A1C is greater or 
equal to 8.5% at the time of diagnosis, suitable drug therapy such as metformin along 
with lifestyle intervention must be initiated. It is recommended that under this situation 
inclusion of insulin therapy alongside metformin should be considered. And if target is 
not achieved in three to six months, adjustment or addition to medication regimen is 
recommended until target is achieved (Harper et al., 2013). If patient shows clear 
symptoms of hyperglycemia plus obvious sign of metabolic decomposition at the time of 
diagnosis, management under that situation will include the immediate initiation of 
insulin therapy with or without metformin and if target is not achieved within three to six 
months another hypoglycemic agent that is suitable to patient have to included. 
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Adjustment to medication regimen is recommended until target is achieved (Harper et al., 
2013). 
Nutrition 
The overall objectives of nutritional therapy are to sustain or advance better 
quality of life and prevent complications and other disorders associated with diabetes 
(Dworatzek et al., 2013). Nutritional therapy which is a very important component of 
diabetes management have been documented by multiply studies to lower AIC by up to 
2% (Dworatzek, et al., 2013; Gaetke, Stuart, & Truszczynska, 2006). Some studies have 
suggested that even better outcomes such as decreased rate of hospitalization are noticed 
when nutrition therapy is implemented concurrently with other methods of diabetic care 
(Imai, Kozai, & Matsuda, 2008; Robbins, Thatcher, & Webb, 2008). Also regular follow-
up (i.e., once every three months) have been shown to be associated with better nutrition 
compliance in people with type 2 diabetes (Huang, Hsu, & Wang, 2010). Balanced diets 
that are low in calories have been shown to help in maintaining a better, healthier body 
and subsequently better glycemic control (Look AHEAD Research Group, 2010). The 
current CDA clinical guidelines for mutational therapy recommend that diabetes patients 
should eat from the different varieties of foods, from all four food groups, including grain 
products, vegetables and fruits, meat and alternatives, and milk and alternatives, while 
consuming more foods that are high in volume and low in calories. It also recommended 
that only between 20% to 30% of calorie of daily energy intake come from fat, 15% to 
20% from protein, 45% to 60% from carbohydrates, and less than 7% from saturated fats. 
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Some studies have shown that diabetes patients find it difficult to adjust to diet change 
(Chowdhury et al., 2000; Nelson, Reiber, et al., 2002). Analysis of the NHANES III 
study by Nelson, Reiber, et al. (2002) showed that 61% of respondents derived more than 
10% of their total daily energy intake from saturated fats, 42% of them obtained 30% to 
40% of their energy intake from fat, 26% got more than 40% of their daily energy intake 
from fat, and 62% of the respondents reported not consuming up to five servings of fruit 
and vegetables daily (Nelson, Reiber, et al., 2002). 
Weight Management 
Weight management is another important integral in diabetes management. About 
80% to 90% of patients with type 2 diabetes are overweight (Wharton, Sharma, & Lau, 
2013). The main objective for the treatment of overweight and obesity in individual with 
diabetes is to use health behavior intervention to attain best possible metabolic and 
glycemic control. Health behavior interventions that are composed of dietary adjustment, 
improved and more frequent physical activity in addition to behavior therapy have been 
demonstrated to be very effective (Wharton et al., 2013; Wing et al., 2001). Studies have 
shown that a moderate loss of 5% to 10% weight can significantly result in better 
sensitivity to insulin, blood glucose control, dyslipidemia, and blood pressure (Wharton 
et al., 2013). The Look AHEAD Research Group (Action for Health in Diabetes; 2010) 
study sponsored by the National Institutes of Health was designed to study how lifestyle 
intervention affects alteration in weight, physical fitness, cardiovascular events and risk 
factors in individuals living with diabetes. Data gathered from the first and fourth year of 
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this multicenter study indicated that a 5% to 10% loss in weight produced significant 
health benefits in the study participants, these benefits includes better glycemic control, 
lower lipid profile, decrease blood pressure and reduction in cardiovascular events and 
risk factors (Look AHEAD Research Group, 2010; Wharton et al., 2013). 
Literature Review Related to Study Methodology 
This research is a quantitative research that will use a cross-sectional design 
method to evaluate factors related to diabetes medication adherence in Cambridge. 
According to Frankfort-Nachmias & Nachmias (2008), cross-sectional design is a 
prominent design method in several social science studies. Fedrick & Justin-Temu (2012) 
conducted a cross-sectional study to determine the factors associated with nonadherence 
to medications by diabetes patients in the city of Mwanza, Tanzania. The authors 
specifically investigated the association between nonadherence and several variables 
which included alcohol consumption, distance of clinic to patient’s home, medications 
side effects, knowledge relating to diabetes treatment and related complications. The total 
numbers of diabetes patients interviewed in this study were 272. Respondents, 43.4% of 
whom were males, were selected from two diabetes clinics in Mwanza. The average age 
of participants was 51.22. The authors of this study fail to indicate how they calculated 
their sample size and also did not state the limitations of this study. The results of this 
research showed that 98% of the respondent claimed that they are very well informed 
about diabetes and diabetes management, thus eliminating diabetes knowledge as a 
possible factor that contribute to nonadherence. However, 28% of participants reported 
56 
 
that they did not adhere to their diabetes medications. Medication adverse effects, alcohol 
consumption, and long distances between patients’ home and clinic location were noted 
to be the important variables that contributes to nonadherence in this study (p = 0.001). 
The authors of this study maintained that nonadherence to prescribed medications was the 
reason for poor health outcomes among diabetic patients (Fedrick & Justin-Temu 2012). 
Sweileh et al. (2014) conducted a cross-sectional study to investigate the 
influence of belief, diabetes knowledge on adherence to diabetes medication. This study 
was conducted in Palestine, in a primary healthcare diabetes clinic located at Nablus. In 
this study, the Morisky instrument (MMSA-8©) was used to determine medication 
adherence. Knowledge related to diabetes was determined with the aid of the Michigan 
Diabetes Knowledge Test and beliefs related to the necessity of medications were 
assessed with the aid of structured questionnaire. SPSS 20 was used for multivariate and 
univariate analysis of data. The numbers of respondent included in this study were 4007 
diabetic patients. Their age range was 28 to 90 years old. Percentage of females was 
53.3%. The average standard deviation of age of respondents was 58.3 ± 10.4. Data from 
this study shows that about 42.7% of research sample were nonadherent (MMAS-8© 
score of  <  6). Also, the results of this study indicated that the following factors were 
significant contributors to nonadherence; diabetes-related knowledge, beliefs related to 
the need for diabetes medications, concern about implication of side effects from diabetes 
medications and general beliefs that medicines causes harm. Study participants with high 
knowledge about diabetes and those that belief strongly in the benefit of their diabetes 
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medications were more likely to be compliant ([O.R = 0.87, 95% CI of 0.78–0.97] and 
[O.R = 0.93, 95% of 0.88–0.99], respectively). Nonetheless patients that were very 
concern about the consequences of the side effects of diabetes medications and those that 
have strong belief that medications are generally harmful were less likely to adhere to 
their medications ([O.R = 1.09; 95% C.I of 1.04–1.16] and [O.R = 1.09, 95% C.I of 1.02–
1.16] respectively). Limitations of the study include the following; firstly, the self-report 
method used for assessing medication adherence could results in overestimation of 
adherence to medications. More reliable estimates of adherence could be obtained by 
direct methods. Secondly, the Validity of the Morisky Medication Adherence Scale 
(MMSA-8©) Arabic version used for this study have not been ascertained, consequently 
this could lead to incorrect conclusions. Thirdly authors of this study are of the view that 
the sample size is not large enough to represent the Palestine population, fourthly since 
no A1C data was used in this study, it not possible for the authors to link glycemic 
control with knowledge, belief and adherence (Sweileh et al., 2014). 
Gelaw et al. (2014) conducted a descriptive cross-sectional study in Ethiopia to 
examine the extent and factors promoting nonadherence among diabetics who attended 
Adama Referral Hospital diabetes clinics. Participants numbered 270, and were 18 years 
old and over. The study response rate was 98.3%, of whom males constituted 51.5%, and 
the percentage of married individuals in the study was 68.1%. Participants that were less 
than 40 years of age made up 14% of study of the group and 50% of the participants were 
between 40 and 60 years old. Selection was done by choosing every other patient and 
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structured questionnaire was used to obtain information regarding adherence to 
medications. Version 16 of predictive analytical software was used for data analysis and 
management. Descriptive statistics was used to analyze sociodemographic data, and 
logistic and correlation analyses were also conducted in this study. Gelaw et al. (2014) 
failed to indicate the limitations of this study and the ethnicity of study participants were 
not revealed. Results from the study show that 21.1% of the study participants blamed 
their nonadherence on forgetting to take their diabetes medications. Participants with 
diabetes history of five years and below (82.07%) were noted to be more compliant to 
taking their medications while individuals with diabetes duration of more than five years 
(60.8%) were less compliant. The investigator stated that this difference was significant 
(P = 0.003). Hypertension (54.84%) and eye impairment (32.96%) were noted to be 
commonly associated with diabetes. The percentage of female patients who adhered to 
their diabetic medications was noted to be higher (74.81%) when compared to the male 
patients (69.78%). This difference was noted by the investigators as not statistically 
significant (P > 0.05). The authors concluded that poor glycemic control among 
participants was mainly due to poor adherence to recommended medication regimen, 
poor knowledge about diabetes, inadequate knowledge about diabetes management and 
failure to practice diabetes self-management (Gelaw et al., 2014). 
A cross-sectional prospective research was conducted by Nozaki et al. (2009) to 
determine the relationship between glycemic control and psychological factors. The 
authors used psychological tools to measure this relationship. The method of analysis was 
59 
 
multiple regression analysis. A total of 304 diabetes participants that regularly visit an 
out-patient clinic for treatment were engaged for this study. Respondent were made to 
take the A1C test at the start of the study. Respondent were also made to complete the 
following self-report psychological inventories: Well-Being Questionnaire 12 (W-BQ12), 
Diabetes Treatment Satisfaction Questionnaire (DTSQ), Social Support Scale, Self-
Efficacy Scale, Self-Esteem Scale (SES), Social Support Scale and Problem Areas in 
Diabetes Survey (PAID). Information regarding participant’s age, medical history was 
also collected. Results from data analysis shows that there is a statistical significant 
relationship between diet management, microvascular problems of diabetes Type II, age, 
and the scores from the PAID, SES, DTSQ, self-efficacy scale and W-BQ12. Participants 
A1C were again measured after one year. Multiple regression analysis was used to 
analyze the data of 219 respondents (95.4% of the 304) after one year. The results shown 
that PAID and DTSQ predicted a lower medication adherence and glycemic control. 
Limitations of this study included: self-management and self-care were not correlated 
with adherence to medication; and 14 of the study’s respondents were not followed and 
four of them passed away during the study. The authors were of the opinion that the 14 
patients may have been more dissatisfied with their management plan. The authors were 
unable to determine if there were any similarities or difference between psychosocial or 
sociodemographic variables after one year. The establishment of a correlation between 
patient satisfaction and glycemic control is a major strength of this study. Patient 
satisfaction means a better quality of life. Respondents that were satisfied had no problem 
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adhering to their healthcare providers’ treatment plans. In their conclusion Nozaki et al. 
(2009) recommended that more multiple regression analysis investigations that include 
the following variables; age, gender, socio-demographics, and quality of life satisfaction 
are needed in future (Nozaki et al., 2009). 
Khan et al. (2012) conducted an investigation to identify factors promoting 
noncompliance among diabetes patient in Saudi Arabia. In this cross-sectional study 
conducted in Al Hasa community of Saudi Arabia, the authors used random sampling 
technique to select 535 diabetes patients from three chronic disease clinics. Data were 
collected from patient’s clinic file records and interview questionnaires. This study 
started on June 2010 and ended on June 2011. The numbers of individuals that finally 
participated in this research were 468 diabetic patients. 67 declined, resulting in 87.47% 
response rate. Participants who were selected were those that have had diabetes for at 
least one year. Most had been on the same diabetes medications for not less than six 
months, had been prescribed adequate doses of diabetes medications, and had been well-
educated on diet and physical activities. Patients who failed to follow medical directives 
and had A1C that is greater than 7% during the time of interview were regarded as 
noncompliant. The following data were collected for this study: age; level of education; 
marital status; gender; duration of diabetes; name of other chronic diseases; disease 
control status; numbers of medications that a patient was taking; frequency of follow-up 
with doctor; and adherence to medication. Statistical calculations were done with the aid 
of version 13 of SPSS. Khan et al. (2012) failed to indicate the limitations of this study 
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and also did not show how they calculated the study sample size. Results of this study 
show that the total prevalence of medication noncompliance among study participants 
was about 67.9% (n = 318, 95% CI 63.59–72.02%). The prevalence of noncompliant 
females (65.45%, P =.003) was lower than males (69.34%). The noncompliance 
observed among those who lived in rural areas was significantly lower than among those 
who lived in an urban area (60.15% vs 71.04%, p = 0.023). Education was also noted to 
influence noncompliance. Bivariate analysis shows that factors significantly linked with 
noncompliance include: education status (OR = 5.27, CI = 4.63–7.19), female gender 
(OR = 1.90, CI 1= .32–4.57), living in urban area (OR 5= .22, CI= 3.65–8.22), 
inconsistent follow-up (OR = 8.41, CI = 4.90–11.92), ), not taking medications as 
prescribed (OR = 4.55 , CI = 3.54–5.56), not adhering to exercise plan (OR = 5.55, CI = 
4.2 6–6.), using insulin (OR = 1.29, CI = .71–1.87) and taking metformin and insulin 
concurrently (OR = 1.20, CI = .65–1.75) (Khan et al., 2012). 
Boswell, Cook, Burch, Eaddy, and Cantrell (2010) conducted a systematic review 
of several original articles that investigated adherence to medications, economic, clinical 
recommendation and/ or use outcomes. The original articles selected for this research 
were studies that concentrated on the North American population. The 13 chronic 
diseases selected for this study were: coronary artery disease (CAD), type 2 diabetes, 
hyperlipidemia, chronic obstructive pulmonary disease (COPD), heart failure (HF), 
asthma, hypertension, postmyocardial infarction (post-MI), seizures, bipolar disorder, 
migraine, depression, and schizophrenia. In this study the researchers’ variables of 
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interest included adherence, costs, outcomes, hospitalization, economics, and Medicaid 
and prescription drugs. Data used for this research were collected from 1974 to 2010. The 
authors reviewed 105 primary articles that investigated various chronic diseases except 
migraine. The authors noted 100% outcomes in the relationship between adherence and 
clinical outcome in post-MI, depression, schizophrenia and seizures. COPD was reported 
to have a neutral outcome in the association between adherence to medication and 
clinical outcome, about 75% of outcomes was noted in the relationship between clinical 
outcome and adherence in all the other disease state apart from hypertension that 
demonstrated 64% outcome. In economic outcomes, the authors also reported 100% of 
outcomes in the association between adherence to medication and economic outcomes in 
hyperglycemia and CAD. Results of outcomes for seizures, post-MI was not available. 
HF, asthma, and COPD had the lowest relationships between economic outcomes and 
adherence, and for the remaining five disease states, about 50% of outcomes were linked 
to adherence. For utilization outcomes, the authors reported a 100% outcome in the 
association between adherence and use outcome for schizophrenia, post-MI disease states 
and about 75% of use outcome were linked to adherence in hyperglycemia, CAD, 
depression, bipolar disorder and seizures. Boswell et al. (2012) showed from their study 
that medication adherence is an important variable that predict economic, utilization and 
clinical outcome in individuals with chronic diseases, though, outcomes was noted to 
differ across the different disease groups. Limitations of this study included lack of 
literatures on medication adherence in migraine management. Also, only very few 
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literatures relating to some of diseases of interest were available, this consequently 
prevented an in-depth evaluation of adherence and health outcome in COPD and seizure. 
Furthermore, researchers focused mainly on individual outcomes instead of holistically 
evaluating the consequence of medication adherence and how to promote adherence. 
Boswell et al. suggested further future research including independent variables that 
specifically addressed particular chronic disease, such as type 2 diabetes. 
Crossman, Nguyen, Slavik, & Allan (2008) conducted a study to determine the 
number of patients visiting the Lion Gate Hospital Diabetes Center for whom medication 
therapy, laboratory targets, and monitoring frequencies were achieved as recommended 
by the CDA clinical practice guidelines of 2003. Consecutive individuals with type 2 
diabetes were selected and added as study participant. Of the total of 349 type 2 patients 
selected for this study, only 48% of this number met the inclusion criteria. Medical 
records of participates were reviewed and the age range o participants was 19 to 69 years. 
Data were tabulated using Microsoft Excel 2000. Standard deviation or the root-mean-
square deviation and the means were recorded as normally distributed data while the 
interquartile range and median were recorded as skewed data. The results of data analysis 
showed that for the majority of the patients, the recommendation for monitoring 
frequencies were achieved, but recommendation for appropriate medication therapy and 
laboratory targets were not met. The most important strength of this research was its 
broad appraisal of a wide selection of diabetes management quality Indicators which 
included medication use, laboratory targets and monitoring frequencies. The researchers 
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also stated that this is the only study that has that evaluated adherence to the 2003 
Canadian diabetes clinical practice guideline. Unfortunately, the fact that this was a 
retrospective design, this research, did not identify the main reasons for poor adherence 
to laboratory targets and medication prescription criteria’s in this population of patients. 
Another limitation was the lack of control group which would have enables true 
comparison of the study and the control groups. Authors also reported limited access to 
laboratory results which could have resulted in the wrong estimation of laboratory 
frequencies. Self- reporting of pharmacological therapies could have result in the low 
estimation of medication usage (Crossman et al., 2008). 
For the past 15 years the CDA has relentlessly tracked the amount individual 
diabetic patients spend on medications, strips and devices by using type 1 and type 2 
diabetes composite case studies. The result of the study shows that 57% of diabetes 
patients in Canada reported that they find it difficult to adhere to their recommended 
treatment plan as a result high out-of-pocket cost needed for medications, supplies and 
devices. The authors of the study noted that the high out-of-pocket cost is due to less 
access to both public and private insurance (Canadian Diabetes Association, 2015). In 
Canada studies relating to diabetes care and adherence to diabetes medications are scanty. 
Cross-sectional and retrospective data shows that there is a low adherence to the 
Canadian diabetes guideline for diabetes management (Crossman et al., 2008; Meltzer et 
al., 1998). Only about half of diabetic patients interviewed during a national population 
survey indicated that they saw their eye specialist in the previous year (James, Young, 
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Mustard, & Blanchard, 1997). Data relating to prevention and screening for other 
diabetes complications are hard to find. Although the national population survey data 
indicated a high rate of adherence to blood pressure screening, very few areas of diabetes 
care were examined (James et al., 1997).One retrospective research that had a small 
numbers of participants (n = 118) indicated that primary care practitioners and patients in 
Canada poorly adhere to Canadian diabetes clinical guideline or diabetes management, 
only 53% of patient show evidence of A1C test, 31% of patients adhere to foot care 
examination and 54% visited their eye doctor in the past year (Worrail, Freake, Keiland, 
Pickle, & Keenan, 1987). Large prospective studies on diabetes care are not available, 
and as a result it is difficult to make any definitive conclusions about diabetes care and 
adherence to medication in Canada. 
Description of Independent and Dependent Variables 
The objective of this research is to establish if there are factors associated with 
adherence to oral diabetes medications among type 2 diabetes patients in Cambridge by 
means of a quantitative design method. This study will explore the relationship between 
independent variables (age, gender, income, level of education and diabetes knowledge) 
and the dependent variables (adherence to diabetes medications) among individuals with 
type 2 diabetes in Cambridge. 
Age Factor 
Age has been shown to be an important factor in the development of type 2 
diabetes (Canadian Diabetes Association, 2011b; Cuasay, Lee, Orlander, Steffen-Batey, 
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& Hanis, 2001). Elderly Canadian seems to be more likely to develop the disease; from 
2005 to 2006, an estimated 1 in 5 (22%) of elderly Canadian were diagnosed with type 2 
diabetes mellitus. This represent about 10 times the number observed among adults 
Canadians 35 to 39 years old, which had a prevalence of 2.3% or one in 47 (Canadian 
Diabetes Association, 2009; Public Health Agency of Canada, 2011). In a study 
conducted by in the United States by Cuasay et al. (2001) to determine the prevalence of 
diabetes among the different Filipino Americans age groups living in Houston, the 
authors used a sample size of 831 participants and study was conducted from September 
1998 to March 2000. The results showed a prevalence of 34.2% among individuals aged 
65 to 74 years compared to a prevalence of 5.6% observed among those that were 35 to 
44 years old. 
Several factors place older adult at risk for issues in diabetes medication 
management (Nikolaus et al., 1996). Seniors in the young-old age group (ages 66 to 74) 
have been noted to be more adherent to their medications when compared to the middle-
aged older adults. After their 75th year, seniors show decreased understanding of 
medication instruction (Guo, Chang, Chang, Wang, & Yeh, 2008). Other factors that 
promote poor adherence in elderly include cognitive decline and poor vision, medication 
side effects and inadequate knowledge of the medication that they take (Nikolaus et al., 
1996). Cramer (2004) and Garcia-Perez, Alvarez, Dilla, Gil-guillen, and Beltran (2013) 
noted from their studies that age was a strong determinant of adherence to diabetes 
medications. However some other studies reported that patient’s age was not associated 
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with adherence or nonadherence to diabetes medication regimens (Khan et al., 2012; 
Nozaki et al., 2009). This study will nonetheless test the strength association between age 
and adherence to oral type 2 diabetes medication regimen in Cambridge. 
Gender Factor 
In Canada, the probability of developing diabetes mellitus rises with age, 
particularly after age 40, increasing from 4.6% of women and 6.3% of men aged 45 to 54, 
to14.8% of women and 22.1% of men aged 65 and older (Canadian Diabetes Association, 
2011). In the first half of last century, type 2 diabetes was noticed to be more among the 
female population but now it is shown to be equally prevalent among women and men in 
most population, with some indication of male excess in early middle age (Gale & 
Gillespie, 2001). 
Pond, Sturock, and Jeffcoate (1996) showed that diabetes control is better in men 
than in women at all ages from about 16 years onwards (Pond et al., 1996). This 
difference in adherence between men and women may be as a result of the fact that 
women more often have to cope with care of their family as well as their diabetes. 
However, Khan et al. (2012) showed from their study which evaluated several factors 
that promote adherence to diabetes medication that women were better adherers to 
diabetes medication than men. A cohort study conducted recently in Germany to evaluate 
the gender differences in relation to diabetes medication adherence and poor blood 
glucose control in type 2 diabetes patients showed considerable gender-specific 
differences in the relationship of adherence and poor glycemic control. Finding from this 
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study shows that 23% of men and 24% of females did not adherent to medication. In men, 
poor blood glucose control was noticed in 37% of the study participants reporting 
nonadherence to medication and in 19% of participant reporting adherence. Whereas, 
among the women, poor glucose control was noticed in 19% of the study participants 
reporting nonadherence to diabetes medication and in 18% of study participants reporting 
adherence (Raum et al., 2012). In a cross-sectional study conducted by Gelaw et al. 
(2014) in Ethiopia to examine the extent and factors promoting nonadherence among 
diabetics who attended Adama Referral Hospital diabetes clinics, the authors engaged a 
study sample of 270 participants. The result of the study shows that across gender, the 
rate of adherence differed, and females were more adherent, 74.81%, compare to males, 
69.79%. This study will evaluate the strength of association between gender and 
adherence to diabetes medications in Cambridge. 
Level of Education 
Ability to read and understand the instructions of how to take prescribed 
medications is an important factor that promote adherence to medications; hence 
individual with higher education profile have the advantage of understanding prescription 
instructions with less difficulties. Gelaw et al. (2014) found a strong association between 
higher level education and adherence to diabetes medication. In their study, they noted a 
higher adherence rates among patients with diplomas (80.77%) and individuals with 
secondary school education (80%). In a cross-sectional study conducted in Eastern 
Uganda to determine the factors promoting adherence to diabetes medication, study 
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sample which was made up of 521 diabetes patients were recruited from Bugiri and 
Iganga hospitals. The study took place from October 2012 to January 2013. Participants 
were 18 years and older and have been on diabetes medication for not less than one 
month. Questionnaire used for the research was pretested. Variables that were tested 
included sociodemographic characteristics, and self-management efforts. The authors 
assessed adherence by using self reports. Inferential and descriptive statistics were 
conducted to evaluate adherence to diabetes medications and the related factors. The 
result of study shows that participant’s sociodemographic characteristics such as sex, 
marital status and education level are not linked to adherence to diabetic medication 
(Bagonza, Rutebemberwa, & Bazeyo, 2015). This is in disagreement to the result of an 
adherence study conducted in Saudi Arabia by Khan et al. (2012). Although results from 
studies on the status of level of education on adherences are mixed, this study will 
however evaluate the effect of level of education on adherence to diabetes in Cambridge. 
Diabetes Knowledge 
Most patients with diabetes develop diabetes-related complications as a result of 
poor knowledge of the disease and inadequate insight about glycemic control. Patient 
education is one of the most effective ways of managing diabetes and reducing 
complications (Mulcahy et al., 2011). Al-Qazaz et al. (2011) conducted a cross-sectional 
research with a convenience sample of 540 adults with type 2 diabetes. The aim of the 
study was to determine the association between diabetes knowledge, medication 
adherence and glycemic control. The instruments used in included a questionnaire, a 
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validated Michigan Diabetes Knowledge Test, and the Morisky Medication Adherence 
scale. Patients’ medical records were reviewed for disease-related information and 
glycosylated haemoglobin levels (HbA1C). The authors excluded 35 patients after data 
collection because of nonavailability of their HbA1C results. The result of their study 
shows a strong relationship between diabetes knowledge and medication adherence  
(P < 0.05) in patients with lower HbAIC levels. Also multivariate analysis shows that 
predictors of good glycemic control includes diabetes knowledge, higher adherence to 
medication and use of mono-therapy. The result of this study is in agreement with the 
results of the study conducted in Palestine by Sweileh et al. (2014). Colleran, Starr, & 
Burge (2003) conducted a study to test the association between diabetes knowledge and 
blood glucose control by using the Michigan Diabetes Knowledge Test to measure 
diabetes knowledge along with measuring patient’s HBA1C. The results of their study 
showed that better diabetes knowledge scores were inversely related to lower HbA1C 
levels (r = -0.337, P < 0.003), signifying that higher knowledge scores positively 
impacted glycemic levels (Colleran et al., 2003) 
Nonetheless, diabetes knowledge does not always guarantee the attainment of 
good blood glucose control. A cross-sectional study conducted in Shanghai, China by He 
and Wharrad (2007) among 60 outpatients and 40 inpatients showed that there was no 
significant difference in diabetes knowledge among participants for suboptimal or good 
blood glucose control. However, the result of the study shows a negative association  
(r = -0.208, P = 0.038) between age and diabetes knowledge. Also occupation associate 
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significantly with diabetes knowledge with those with white-collar jobs having the 
highest mean score (24.84) while the lower mean score (20.67) was recorded among the 
housewives (He & Wharrad; 2007). 
Income 
Paying for the needed supplies of medications for the management of chronic 
illness like diabetes involves huge financial commitment. Investigators have showed that 
patients inability to purchase diabetes medication play a vital role in adherence to 
diabetes therapies (Nagelkerk, Reick, & Meengs, 2006). Researchers have also found a 
significantly strong inverse relationship between out-of-pocket payment for type 2 
diabetes medications and adherence to diabetes medication regimen (Karter, Ferrara, et 
al., 2000). Consequently, prescribing cheap and effective diabetes medication such as 
metformin could promote adherence to medication especially for individuals who are 
uninsured. The continued increase in the cost of medications can further enhance low 
adherence to medication regimen by individuals with chronic conditions including 
diabetes (Horswell, Wascom, Cerise, Besse, & Johnson, 2008). Sokol, McGuigan, 
Verbrugge, and Epstein (2005) showed that for hypercholesterolemia and diabetes 
optimal level adherence to medication regimens was linked to lower disease-associated 
medical cost in uninsured diabetes patients. Chernew et al. (2008) conducted a research 
to determine the consequences of increased patient’s healthcare cost sharing on the 
various socioeconomic groups in healthcare. The objective of the study was to add to the 
body of studies on out-of-pocket expenses and adherence by exploring the association 
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between copayments and adherence to prescribed medications across the various income 
groups in the United States. The result of their study shows that individuals living in high 
income areas were more likely to adherence to their prescribed prescriptions in spite of 
increase in copayment or increase in medical share cost. However, the study indicated 
that adherence to medications was more likely to decrease when there is an increase in 
copay for medication among patients that are low income earners, this finding shows that 
a raise in patient out-of-pocket expenses for prescribed drugs can simply result in low 
adherence to prescribed medication among the poor. This study is in agreement with the 
results of an adherence study conducted in Ethiopia by Gelaw et al. (2014). In a study 
conducted in Canada to determine the impact of cost on medication adherence. The 
authors used data obtained from 2007 Canada community survey for their research. 
Responses of 5732 participants that answers question relating to cost-associated 
nonadherence to treatment were analyzed. The authors determined national prevalence of 
cost-associated nonadherence to treatment and logistic regression was used to evaluate 
the link between cost-associated nonadherence and several socioeconomic and 
demographic variables, including sex, age, province of residence, household income, 
having drug insurance and health status. Results of the study show that 9.6% (95% 
confidence interval [CI] 8.5%–10.6%) of Canadian reported that cost was the reason for 
their nonadherence to their medications. The study also shows that lower income (OR 
3.29, 95% CI 2.03–5.33), poor health status (odds ratio [OR] 2.64, 95% CI 1.77–3.94), 
individuals without drug insurance (OR 4.52, 95% CI 3.29–6.20) and those residing in 
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British Columbia (OR 2.56, 95% CI 1.49–4.42) were more likely to report that cost is the 
reason for their nonadherence to prescribed medications. Predicted percentage range of 
cost-associated nonadherence is from 3.6% (95% CI 2.4–4.5) among individuals with 
drug plan insurance and household with high incomes to 35.6% (95% CI 26.1%–44.9%) 
among individual without insurance and household with low incomes (Law, Cheng, 
Dhalla, Heard, & Morgan, 2012). 
Adherence to Type 2 Diabetes Medication 
The dependent variable for this research is adherence to oral diabetes medications. 
Healthcare practitioners and investigators have proposed various definitions for 
adherence to treatment. Mihalko et al. (2004) defined adherence to therapy as the extent 
of involvement that is expected of a patient that have accepted a prescribed management 
regimen. Farmer et al. (2008) and Cramer (2004) defined adherence to treatment as an act 
of taking prescribed medications regimen as recommended or agreed between prescribed 
and patients. According to WHO (2003), adherence to therapy is “the extent to which a 
person’s behavior-taking medication, following diet, and, or executing lifestyle changes, 
corresponds with agreed recommendations from a healthcare provider” (p. 3). For 
investigators to adequately measure adherence to treatment regimen, it is important to 
develop a consensus definition for adherence to therapy. 
Optimal glycemic control of type 2 diabetes requires strict adherence to oral 
diabetes medications regimens (Canadian Diabetes Association, 2013; Khan et al., 2012). 
High level adherence is vital in preventing mortality, morbidity and maintaining adequate 
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glycemic control (Chernew et al., 2008). In some cases, higher adherence has been shown 
to result in even lower total healthcare expenditures (Sokol et al., 2005). In a quantitative 
research conducted by Schectman, Nadkarni, and Voss (2002) with 828 participants, the 
authors discovered that for every 10% rise in adherence to oral diabetes medication 
regimens, A1C reduced by 0.19% (p < .0001). Also Schectman et al. (2002) discovered a 
strong association over time between glycemic control and adherence to oral diabetes 
medication regimens. Similarly Harper et al. (2013) reported a direct relationship 
between adherence to oral diabetes medication and AIC values among Canadians. 
Investigators have shown that apart from resulting in poor disease outcome, low 
adherence to treatment is also a significant contributor to the increasing healthcare cost 
(Bartels, 2004; Guillausseau, 2005). Consequently, identifying factors that promotes 
adherence is vital for the development and implementation of strategies that will help 
promote adherence which will subsequently help to reduce diabetes-related mortality, 
morbidity, and healthcare cost. 
Literature Review on Social Change 
Investigators agree that adherence to diabetes medications help prevent diabetes-
related complications (Canadian Diabetes Association, 2013; Watkins & Connell, 2004). 
Literature review shows that various factors are associated with adherence or no 
adherence to diabetes medications and these factors may differ across different 
communities and ethnic groups (Ciechanowski et al., 2001; Collins-McNeil et al., 2012; 
Marcum & Gellad, 2012; Peyrot & Rubin, 1994). Predictors related to diabetes adherence 
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or non adherence in Cambridge is not known. There is no doubt that adherence is an issue 
in Cambridge, because according to WHO about 50% of individuals with chronic 
diseases, including diabetes, do not adhere to their medications as recommended (Brown 
& Bussell, 2011; Reynolds et al., 2004). Consequently, there is the need to identify those 
factors that influence diabetes adherence in Cambridge. Some of the merits of adhering to 
diabetes medication plan include: good quality of life, fewer diabetes-related 
complications, less financial burden on the patient and the health system, better glycemic 
control, and reduction of incidence of depression and anxiety among diabetes patient. 
This research will promote social change by assisting individual with diabetes to improve 
on their adherence to their medications and also this research will provide useful 
information that will assist healthcare providers to better understand diabetes, the reasons 
for nonadherence and how to better assist patient to adhere to their diabetes medication 
regimens. My aim also is to help provide information that will encourages policy makers 
at the regional and provincial levels to come up with policies and programs that will 
assist diabetes patient in Cambridge to overcome all the barriers that hinder adherence to 
medications and other treatment plans that can promote better quality of life. Assisting a 
diabetes patient to understand the barriers that are hindering them from adhering to their 
treatment plan is vital in the prevention and elimination of the said barriers (Swan, 2010). 
Summary and Conclusion 
This chapter contains the definition of diabetes, diabetes management methods 
and review of several adherence and nonadherence studies that were conducted to 
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improve management of diabetes around the world. This literature review section also 
included a synopsis of research designs and methodologies used in various adherences, 
nonadherence studies. Summaries of several theories that are related to medication 
adherence also formed a major part of the section. Also included in this section is a 
summary of the interventions targeted to improve adherence to diabetes management 
plans through patient participation in recommended physical activities, proper nutrition, 
weight management and health education. Chapter 3 contain in-depth description of 
research design, methodology, and recruitments of participants, sample size, ethical 
considerations and data analysis are provided. There is no information in the literature 




Chapter 3: Research Method 
There are no existing studies regarding adherence to diabetes medication 
regimens among diabetes patients in Cambridge . In this investigation I explored the 
factors that are linked to adherence to diabetes treatment in Cambridge using a cross-
sectional approach. This chapter includes an in-depth description of study design, 
population, sampling method, instrumentation, organization of constructs, and ethical 
considerations related to participants. The chapter also contains the rationale for the 
selection of the quantitative study design used for this study. The participant recruitment 
method and the size and characteristics of the sample are presented in this chapter as 
well. The instruments used are described, as are the procedures for data collection and 
analysis. Threats to validity are presented at the end of the chapter. 
Research Design and Rationale 
A quantitative approach was used in this research to investigate the problem, 
which was low levels of adherence to prescribed diabetes treatment regimens in 
Cambridge. Investigators have identified that up to 50% of patients with chronic diseases 
including diabetes are nonadherent to their medications (Cramer, 2004; Krousel-Wood, 
Muntner, Islam, Morisky, & Webber, 2009). In this study, correlational cross-sectional 
study design was used to explore the factors that are linked to adherence to diabetes 
medications among diabetes patients in Cambridge. The factors that were investigated 
included age, gender, level of education, and diabetes knowledge. The quantitative 
method was appropriate for this study because data collection occurred by survey method 
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and the study questions were closed-ended (Creswell, 2009). The objectives of this study 
did not include observing or interviewing patients in their natural environment (Creswell, 
2009). Thus, the qualitative method was not considered for this study. Moreover, cross-
sectional design was most suitable for this study because the intention of this research 
was to ascertain the empirical relationship between the independent and dependent 
variables. Nonetheless, the goal of this research was not to determine causation 
(Campbell & Stanley, 1963). The predictive or independent variables were age, gender, 
level of education and diabetes knowledge, and the outcome or dependent variable was 
adherence to type 2 diabetes medications. A number of bivariate analyses were conducted 
for the independent variables in order to determine the link between the independent 
variables and adherence to medication (dependent variable). Additionally, multivariate 
analyses were conducted for each of the combination of variables to establish whether the 
group of two variables formed a more significant predictor than one variable alone. 
Setting 
This research was conducted at pharmacy located in the downtown area of Galt, 
Ontario. This pharmacy was chosen because it has clients with diabetes from all of the 
communities in the Cambridge area. The focal point of this research was communities in 
Cambridge, which has population of about 200,000 people of various backgrounds and 
ethnicities. Pharmacies in Cambridge are actively involved in helping diabetes patients to 
comply with their diabetes medication regimens through diabetes prescription refill 
reminder programs and diabetes educational clinics. A good number of adults in 
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Cambridge find it difficult to pay for their diabetes medications and also fail to keep 
doctor’s appointments. As a pharmacist in Cambridge, I have noticed over the years that 
many individuals with diabetes fail to refill their medications when they are due. As a 
result, many diabetes patients end up with diabetes complications, mainly due to 
nonadherence to their diabetes treatment regimens. Patients ‘ability to purchase needed 
diabetes medications plays a vital role in adherence to diabetes therapies(Nagelkerk et al., 
2006). Studies have shown a significantly strong inverse relationship between out-of-
pocket payment for type 2 diabetes medications and adherence to diabetes medication 
regimen (Karter, Ferrara, et al., 2000). A Canadian study also reported that lower income 
earners (OR 3.29, 95% CI 2.03–5.33), individuals without drug insurance (OR 4.52, 95% 
CI 3.29–6.20) were more likely to report that cost was the reason for their nonadherence 
(Law et al., 2012). 
Population 
The study participants for this research were individuals who filled their 
prescription at Metro Pharmacy, Cambridge. These individuals had a history of diabetes 
and were living in the Galt, Preston, and Hespeler communities of Cambridge. 
Participants were men and women 18 years of age and older who had been receiving 
treatment for their diabetes for at least one year. Researchers have shown that diabetes is 
on the rise in most parts of Canada, including in the province of Ontario, where 
Cambridge is located (Canadian Diabetes Association, 2009, 2011; Crossman et al., 
2008; Public Health Agency of Canada, 2011). Identifying factors that influence 
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adherence to diabetes management plans may benefit patients, private drug insurance 
providers, stakeholders in government, and health practitioners who are involved in 
diabetes care in Cambridge communities. Participants in this study willingly took part in 
it, without being subjected to any form of pressure. 
Sampling and Sampling Procedures 
This research used convenience sampling. The individuals who were engaged as 
study participants filled their prescriptions at Metro Pharmacy Limited in Cambridge. 
Diabetes patients were informed of the research during prescription counseling sessions 
and when they came to the pharmacy to pick up their medications. Those recruited were 
given the consent form to complete. Fifty-nine individuals were recruited for the study, of 
whom 56 filled out the questionnaires completely. 
Sample Size Calculation 
This investigation involved four independent (age, gender, level of education, and 
diabetes knowledge) and one dichotomous dependent variable (adherence to type 2 
diabetes medication). Logistic regression was used for statistical analysis. Statistical 
power analysis for logistic regression was carried out by following the guidelines, 
established in G*Power 3.1.7 (Faul, Erdfelder, Buchner, & Lang, 2013) and Lipsey and 
Wilson (2001) to calculate a sufficient sample size by using an alpha of 0.05, power of 
0.80, and a medium effect size (odd ratio = 1.72) with a two-tailed test. Given the values 
obtained, the required sample size to accomplish empirical validity for logistic regression 
analysis with four predictors is a minimum of 117 patients as computed using the 
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G*Power 3.1.7 calculator . Consequently, this study required a minimum of 117 
participants. However, the final sample size consisted of 56 participants, because it was 
difficult to find more patients to volunteer for the study. 
It is possible that a larger number of participants may have produced outcomes 
different from the ones reported in this study. A larger sample might have covered a 
broader geographical area and a more diversified population than the one used in this 
research. Future researchers in this area may consider using a larger sample size in order 
to obtain results that are more representative. 
Procedures for Recruitment, Participation, and Data Collection and Analysis 
Metro Pharmacy Limited, Cambridge, was used as a recruitment and test 
administration center. Recruitment materials were offered to patients at the prescription 
pickup area of the pharmacy. Volunteers were recruited by informing them about the 
research during clinical interaction and medication counseling sessions. During the 
recruitment drive, exclusion and inclusion criteria were emphasized, and volunteers that 
met the inclusion criteria were given the informed consent form. Participants that handed 
in completed informed consent forms were advised of the time and location for the test, 
and each study volunteer was given a personalized identification number. The 
demographic survey instrument used for this research was adapted from the WHO 
STEPS instrument. This instrument is in the public domain (World Health Organization, 
2017). Answering the survey questions took between one and two hours. Once a 
participant had completely filled out the survey materials, a thorough check of the test 
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material was conducted to ensure that no required data were missing. Results were made 
available to study participants who indicated their intention to receive the results. Results 
were given out in the same way that the survey had been administered. 
The demographic questionnaire was used to collect the following information: 
name, date of birth, gender, education, names of other chronic diseases, household 
income, and marital and employment status. Age was divided into four categories: 35 to 
44 years = 0; 45 to 54 years = 2; 55 to 64 years = 3; and 65 years and over = 3. Gender 
was categorized as male or female. Marital status was defined as married/common-law 
partner, single, divorced/widowed. Employment status was defined as employed or 
unemployed. Income was divided into five categories by annual income: below $200,000 
= 1; $200,00 to $349,999 = 2, $350,00 to $559,999 = 3; $600,00 to $999,999 = 4; and 
$1000,000 and above = 5. Religion was categorized as Christianity, Islam, and others. 
Diabetes education referred to whether the participant had attended diabetes training 
classes. Other health-related information that was collected included: medication 
coverage status (social service funding, private insurance, self-funded); duration of 
diabetes and medication regimen status (number of diabetes medications, number of other 
medications used for other conditions). Level of education was categorized as elementary 
school, high school, college, or university education. 
In addition to the demographic survey questionnaire, the eight-item Morisky 
Medication Adherence Scale (MMAS) and the Michigan Diabetes Knowledge Test were 
used for data collection. Adherence to diabetes medication was tested with the aid of 
83 
 
MMAS, which included questionnaires about adherence to medical therapies. This scale 
was developed from an original highly validated and reliable 4-item scale (Morisky, Ang, 
Krousel-Wood, & Ward, 2008). The 8-item scale is better at capturing barriers to 
adherence behaviors. Various investigators have also shown that the 4-item scale has a 
lower reliability compared to the 8-item scale ([α = .83, vs. α = .61]) (Krousel-Wood et 
al., 2009; Morisky, Ang, et al., 2008). The 8-item scale is allocated a 5-point Likert 
response scale on a range of 0 to 4. The remaining items use a 2-point Likert scale with a 
range of 0 to 1. For Items 1 to 7 on the MMAS, response options are yes or no. A score of 
1 is assigned to every no response and every yes response is assigned a 0 score. Item 5 is 
an exception to this pattern, in that every no answer is assigned a score of 0 and every yes 
answer is assigned a score of 1. The highest possible score on the MMAS is 8, and the 
lowest possible score is 0. A score of 8 indicates high adherence, a score of 7 or 6 
indicates a medium level of adherence, and a score of less than 6 is a reflection of poor or 
low adherence (Morisky, Ang, et al., 2008). 
Ethical Protection of Participants 
The rights and privacy of participants were fully protected in this study. Before 
the start of data collection, an informed consent form was given to each participant. 
Participants were fully informed of their right to not be part of the study before the 
commencement of the research, during the period of the investigation, and after the study 
had concluded. Concerns about patient confidentiality were completely addressed. The 
data obtained from each participant were protected by using a unique code to identify 
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each participant. Transcripts, files, and all other documentation related to the participants 
were stored in a securely locked cabinet in my office. Prior to data verification, all 
information that might identify a participant was removed from the transcript. The only 
individual who had access to patient data was myself . Before the start of data collection, 
I applied for and obtained approval for my research methodology from the Walden 
University Institutional Review Board (IRB). The approval number was 
2016.11.2816;4033-06 00 
Validity 
Sample selection bias may have arisen in this study as a result of the convenience 
sampling technique that was used. This potential internal validity issue was addressed by 
recruiting diverse participants the various communities in Cambridge. Threats to external 
validity may arise when there is incorrect generalization from study participants to other 
individuals or the general population (Creswell, 2009). This external validity threat was 
addressed by not generalizing the results of this study to other populations that are 
dissimilar to diabetes patients in Cambridge. Construct validity threat of measurement is 
related to the association between a study’s theoretical framework and instruments used 
for measurement (Frankfort-Nachmias & Nachmias, 2008). The measuring instruments 
used in this study aligned closely with the selected theoretical framework. 
Instrumentation and Materials 
The objective of this research was to establish whether there are factors associated 
with adherence to oral diabetes medications among type 2 diabetes patients in Cambridge 
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by means of a quantitative design method. This study explored the relationship between 
the independent variables (age, gender, income, level of education, and diabetes 
knowledge) and the dependent variable (adherence to diabetes medications) among 
individuals with type 2 diabetes in Cambridge. The instruments used in this study 
included a WHO demographic questionnaire, the MMAS, and the Michigan Diabetes 
Knowledge Test. 
Demographic Questionnaire 
Demographic data were obtained with the aid of the WHO STEPS demographic 
instrument (World Health Organization, 2017; see Appendix A) The demographic 
questionnaire contained questions that related to study participants’ age, gender, 
education, ethnic group, income, family size and employment status. The question about 
age required participants to indicate their exact age. In response to the question about age 
(“What is your date of birth?”), respondents were expected to state their actual birthdate. 
The question about gender required study participants to indicate whether they were male 
or female. In response to the question about marital status (“What is your marital 
status?”), respondents were required to choose the most appropriate answer that applied 
to them from a list that included married, not married, separated, divorced, or 
cohabiting. The question about level of education was “What is the highest level of 
education you have completed?” Participants were required to chose an option from the 
following list: no formal schooling, less than elementary school, elementary school, high 
school, college/university, or postgraduate degree. In response to the question about 
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income or socioeconomic status (“Taking the past year, can you tell me what the average 
earnings of your household have been?”), respondents could choose to indicate this value 
per week, per month, or per year. 
Morisky Medication Adherence Scale 
The dependent variable for this study, adherence to oral diabetes medications, was 
assessed with the aid of the MMAS (Sweileh et al., 2014). The MMAS developed by 
Morisky, Green, and Levine (1986) is the best known and most commonly used 
questionnaire for assessing medication adherence (Čulig & Leppée, 2014). The MMAS is 
made up of eight questions designed to determine patient’s medication adherence status 
(Appendix B): 
1. Do you sometimes forget to take your pills? People sometimes miss their 
medications for reasons other than forgetting? 
2. Thinking over the past two weeks, were there any days when you did not take 
your medicine? 
3. Have you ever cut back or stopped taking your medication without telling 
your doctor because you felt worse when you took it? 
4. When you travel or leave home, do you sometimes forget to bring along your 
medication? 
5. Did you take your medicine yesterday? 
6. When you feel like your diabetes is under control, do you sometimes stop 
taking your medicine? 
87 
 
7. And taking medication everyday is a real inconvenience for some people; do 
you ever feel hassled about sticking to your treatment plan? 
8. How often do you have difficulty remembering to take all your medications? 
(Čulig & Leppée, 2014). 
The first seven questions require a yes or no answer and the last question on the 
adherence scale is answered on a 5-point Likert scale. A point is assigned for each 
sentence based on the participant’s answer. For the first seven questions, one point is 
awarded for each no answer while zero is given for each yes answer. The exception is 
Question 5, where 1 point is awarded for the yes answer and zero is given for a no 
answer. For Question 8, a score of 1 is assigned for never/rarely answer and 0 points is 
assigned for all the time (Sweileh et al., 2014). The total of the MMAS score is the sum 
of the scores for the eight questions. The overall score that is obtained ranges from 0–8. 
In this study, participants with an overall MMAS score of less than 6 were considered 
nonadherent, whereas participants with total score greater than or equal to6 were 
regarded as adherent (Čulig & Leppée, 2014; Sweileh et al., 2014). 
The Michigan Diabetes Knowledge Test 
This diabetes knowledge test (DKT) was used to assess study participants’ 
diabetes knowledge (Appendix D). This validated instrument is the most commonly used 
diabetes knowledge test (Fitzgerald et al., 1998; Quandt et al., 2014). It was developed by 
the Michigan Diabetes Research and Training Center (MTRC) in the mid-1980s. Over 
time, this scale has been updated, resulting in a 23-item knowledge scale single test. The 
88 
 
23 questions on this test assess patient knowledge about diabetes. The test consists of two 
sections: a 14-item general knowledge diabetes test subscale, and a nine-item insulin-use 
knowledge test subscale. The 14-item general knowledge test subscale is used to test 
diabetes knowledge of individuals who do not manage their diabetes with insulin. 
However, the full 23-item test can be administered to individuals who use insulin. Both 
the nine-item insulin use subscale and the 14-item general subscale take about 15 minutes 
to complete. Flesch-Kincaid readability tests place the test’s readability at a sixth grade 
reading level (Fitzgerald et al., 1998). Fitzgerald et al. (1998) conducted a study to 
determine the validity and reliability of the test by administering it to two different 
population groups. At the time of the study, the first group was receiving diabetes care 
from within the community through several different health providers, and the other 
group received all diabetes care from a local health department. 
The authors used Cronbach’s coefficient measure scale reliability for each 
population sample. The coefficient for the insulin-use as well as the general test shows 
that both subscales are reliable (α ≥ 0.70). Cronbach alpha measures the reliability of a 
scale (Cohen & Swerdlick, 1999) A Cronbach alpha score of ≥ 0.70 indicates high 
reliability (Fitzgerald et al., 1998). In spite of the fact that the samples were different 
demographically, the validity and reliability of the DKT were reinforced in both the 
health department and community samples. This shows that the DKT is reliable in 
different settings and also appropriate in a variety of patient populations. In this study a 
14-item subscale was used for the DKT. Each correct answer was assigned one point with 
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the maximum score obtainable being 14. The total score of ≥ 7 was rated as good diabetes 
knowledge while a total less than 7 was rated as poor diabetes knowledge. Higher scores 
indicate higher knowledge of diabetes (Jasper et al., 2014). The DKT and its answer key 
are freely available online and can be downloaded (Michigan Diabetes Research Center, 
2017). 
This study’s research hypotheses and research questions are listed below for 
review. 
RQ1: Are the variables age, gender, diabetes knowledge, and level of education 
associated with adherence to diabetes medication among individuals with 
type 2 diabetes in Cambridge? 
Ho1: There is no relationship between age and adherence to diabetes 
medications among individuals with type 2 diabetes in Cambridge. 
Ha1: There is a relationship between age and adherence diabetes medications 
among individuals with type 2 diabetes in Cambridge. 
Ho2: There is no relationship between gender and adherence to diabetes 
medications among individuals type 2 with diabetes in Cambridge. 
Ha2: There is a relationship between gender and adherence to medications 
among individuals with type 2 diabetes in Cambridge. 
H03: There is no relationship between diabetes knowledge and adherence to 




Ha3: There is a relationship between diabetes knowledge and adherence to 
diabetes medications among individuals with type 2 diabetes in 
Cambridge. 
H04: There is no relationship between level of education and adherence to 
diabetes medications among individuals with type 2 diabetes in 
Cambridge. 
Ha4: There is a relationship between level of education and adherence to 
diabetes medications among individuals with type 2 diabetes in 
Cambridge. 
RQ2: Are any pair-wise combinations of the variables age, gender, diabetes 
knowledge, and level of education associated with adherence to diabetes 
medication among individuals with type 2 diabetes in Cambridge? 
Ho5: The age and gender combination is not significantly linked to adherence to 
diabetes medications among people with type 2 diabetes in Cambridge. 
Ha5: The age and gender combination is significantly linked to adherence to 
type 2 diabetes medication among individuals with diabetes in Cambridge. 
Ho6: The age and level of education combination is not a significantly linked to 




Ha6: The age and level of education combination is significantly linked to 
adherence diabetes medication among individuals with type 2 diabetes in 
Cambridge. 
Ho7: The age and diabetes knowledge combination is not significantly linked to 
adherence to diabetes medication among individuals with type 2 diabetes 
in Cambridge. 
Ha7: The age and diabetes knowledge combination is significantly linked to 
adherence to diabetes medication among individuals with type 2 diabetes 
in Cambridge. 
Ho8: The gender and level of education combination is not significantly linked 
to adherence to diabetes medication among individuals with type 2 
diabetes in Cambridge 
Ha8: The gender and level of education combination is significantly linked to 
adherence to diabetes medication among individuals with type 2 diabetes 
in Cambridge 
Ho9: The gender and diabetes knowledge combination is not significantly 
linked to adherence to diabetes medication among individuals with type 2 
diabetes in Cambridge. 
Ha9: The gender and diabetes knowledge combination is not significantly 
linked to adherence to diabetes medication among individuals with type 2 
diabetes in Cambridge 
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Ho10: The level of education and diabetes knowledge combination is not 
significantly linked to adherence to diabetes medication among individuals 
with type 2 diabetes in Cambridge 
Ha10: The level of education and diabetes knowledge combination is 
significantly linked to adherence to diabetes medication among individuals 

















Figure 3. Fully diluted model with pair-wise fittings. Adapted and modified from “The Theory of Planned Behavior,” by I. Ajzen, 
1991, Organizational Behavior and Human Decision Processes, 50, p. 182. Copyright 1991 by I. Ajzen. Adapted from public 
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All the instruments used in this research (WHO SURE STEPS demographic 
instrument, DK test and MMS) were hand scored and data were collected and entered 
into SPSS version 21 for windows. Descriptive statistics (frequencies, proportion and 
means) were conducted to describe participant’s demographic characteristics and other 
research variables (Gelaw et al., 2014; Khan et al., 2012). Logistic regression analysis 
was employed to test the two hypotheses of this study. Bivariate logistic regression 
analysis was used to test the first hypothesis. The strength of association between each of 
the independent variable (age, gender, level of education, income and diabetes 
knowledge) and the dependent variable (adherence to type 2 diabetes medication) was 
explored with the aid of bivariate logistic analysis (Park et al., 2010). In this analysis 
odds ratio was calculated based on a 95% confidence interval and an alpha level of 0.05 
will be used (Park et al., 2010). Accepting or rejecting the Null hypothesis depend on the 
P-value. If the P-value obtained from the bivariate analysis test of associated between an 
independent variable and medication adherence is less than 0.05, the null hypothesis was 
rejected (Park et al., 2010). This indicated that the independent variable is a strong 
predictor of adherence to diabetes medications among individuals living with diabetes in 
Cambridge. Moreover, if the result shows an alpha value that is greater than 0.05, the 
Null hypotheses was accepted, indicating that the variable is not a strong predictor of 
adherence to diabetes medication in Cambridge. The second hypothesis was tested with 
the aid of multivariate regression logistic analysis to determine the effects of the 
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combination of two independent variables on medication adherence (Park et al., 2010). In 
the multivariate analysis, odds ratio was calculated based on a 95% confidence interval 
and the alpha level that will be 0.05. Accepting or rejecting the Null hypothesis depended 
on the P-value. If the P-value obtained from the test of the multivariate analysis of the 
effect of a combination of two variables on adherence was less than 0.05, the null 
hypothesis was rejected (Park et al., 2010). This showed that the combination is a strong 
predictor to adherence to diabetes medications among individuals living with diabetes in 
Cambridge. Moreover, if the result shows an alpha value that is greater than 0.05, the 
Null hypotheses was accepted, indicating that the combination is not a strong predictor of 
adherence to diabetes medication in Cambridge. 
Logistic regression analysis method is appropriate for statistical analysis when the 
dependent variable is dichotomous with two likely outcomes and the independent 
variables are of any types (Agresti, 1996). The dependent variable in this study is 
adherence to diabetes medication and is determined by whether or not a diabetes patient 
is adherent (MMAS adherence score ≥ 6) or nonadherent (MMAS adherence score <  6) 
to prescribed diabetes medications according to the Morisky scale. The independent 
variables that were tested include: age, gender, level of education and diabetes 
knowledge. Logistic regressions surmount several of the stringent assumptions of linear 
regressions. In logistic regression, normally distributed variables, equality of variances, 
linearity between dependent and independent variables are not assumed, and also it does 
not assume that the error term variance is normally distributed. In general logistic 
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regression does not have stringent requirements. However, in logistic regression, outliers 
must not be present in data, outcome variable must be dichotomous and there must be a 
linear association between the odd ratio and the independent or predictor variables 
(Agresti, 1996; Tabachnick & Fidell, 2001). If outliers are discovered, they will be 
analyzed to ascertain if it due to patient’s error or due to unusual circumstances. Linearity 
with an interval independent or ordinal variable and the odds ratio can be verified by 
creating a new variable that separates the existing independent or predictor variable into 
groups of equivalent intervals and running similar regression on these newly created 
categorical variable or categorized versions. Linearity is established if the B coefficient 
decreases or increases in a linear manner (Garson, 2009). Also larger sizes of samples are 
assumed in logistic regression because maximum likelihood coefficients are large study 
sample estimates. Logistic regression constructs a best fitting function or equation 
(model) by employing the maximum likelihood method, which maximally utilizes the 
probability of grouping the observed data into the proper class with respect to the 
regression coefficients (Agresti, 1996). 
Inferential Statistics 
The overall significance of the logistic regression was determined by examining 
the classification table, the display of the incorrect and correct classifications of the 
outcome variable. In addition, chi- square goodness of fit test was used to test the 
appropriateness of model. Wald statistic was used to determine the significance of each 
of the independent variables. Also EXP (B) value shows the raise in odds from one unit 
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raise in the selected variable (Agresti, 1996). Logistic regression assigns each 
independent a coefficient ‘b’ which measures the predictor variable impact on variations 
in the outcome variable. The Snell R², Cox and Nagelkerke R² used to determine the 
percentage of variance in the dependent variables that is predicted by the predictor 
variable (Field, 2009). Odd ratio value was used to ascertain the probability of the 
occurrence of an event and it is estimated by using the regression coefficient of the 
independent variable as the exponent or exp (Tabachnick & Fidell, 2001).The table of the 
Omnibus test result also contains a list of the predictor variables and the sig column 
which has the p-value for each predictor variable. Preselected alpha value for this 
research is 0.05. Predictors with p-values less than alpha (0.05) were regarded as 
statistically significant. 
Multicollinearity 
Multicollinearity is a situation in which two or more independent variables in a 
multiple regression model are very highly co-associated or correlated, indicating that one 
variable can be linearly predicted from the other variables present in the model with a 
considerable degree of accuracy (O’Brien, 2007). Multicollinearity can result in the 
following; inflate estimates of coefficient variance; produce models in which none of the 
variable have statistical significance; produce coefficient estimates of the “wrong sign” 
and of incredible magnitude; Produce situations in which slight changes in the data 
results in wide changes in coefficients estimates; and, in some extreme situations, 
multicollinearity can hinder the statistical solution of a model (Belsley, Kuh, & Welsch, 
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1980). Problems associated with multicollinearity can be crippling and could result in 
wrong inferences. One way of identifying multicollinearity is looking at the variance 
inflation factor (VIF). This factor determines how much the variance of an approximated 
regression coefficient increases if the independent variables are correlated. If no 
independent variables are associated or correlated, the VIFs will all be 1. 
Multicollinearity can also be diagnosed by Tolerant factor. This factor can be calculated 
by first obtaining the proportion or percentage of predictor variance that overlaps with the 
other independent variable or predictors. This number is then subtracted from 1; Variable 
Tolerance is 1- R2. For instance, if the other independent variables explain 50% of the 
variance in x, the tolerance of x (in a model with those predictors) will be 1 - .5 = .5. 
Most statistical programs like the SPSS reports the results of Tolerance and variance 
factor test. A low or small tolerance value shows that the variable that is being considered 
is almost a perfect linear combination of other predictor variables that are already in the 
equation and as a result it should not be added to the regression equation. Variables that 
are in linear association will have a small tolerance. 
According to Menard (1995), a tolerance value of less than 0.20 is a cause for 
concern and a tolerance value less than 0.10 almost unquestionably indicates a serious 
collinearity or multicollinearity problem. A maximum VIF value that is greater than 10 
usually indicates that multicollinearity may be overly influencing the smallest square 
estimates (Hair, Anderson, Tatham, & Black, 1995; O’Brien, 2007). In this study, SPSS 
was used to check for and identify multicollinearity in the data set by running the 
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tolerance and VIF test. VIF value greater than 10 and tolerance value less than 0.2 will be 
indicative of the presence of multicollinearity (O’Brien, 2007). Multicollinearity can be 
minimized by; removing one of the variable that is highly correlated in the model: 
increasing study sample size, this will generally reduce standard errors; Ensuring that 
flagrant errors has not been made, for example , inaccurate use or entry of dummy or 
computed variables; It might just be best to accept that multicollinearity is present in the 
model and be alert to its consequences; centering the variables, variable can be centered 
by calculating the mean of each predictor variable, and then replace each of the value 
with difference between it and the mean (Belsley et al., 1980). 
Summary 
Chapter 3 contained an in-depth discussion of study methodology and reason why 
quantitative method was selected. Cross-sectional study design was used to explore the 
association between age, gender, level of education, diabetes knowledge, and adherence 
to type 2 diabetes medications among diabetes patients in Cambridge. The location for 
this research was Metro Pharmacy, Cambridge. Individual that accepted to participate in 
this research were given a coded research package that contains study questionnaires. 
Study participants were asked to complete the MMAS, diabetes knowledge test, and the 
demographic questionnaires. Bivariate and multivariate logistic regression analyses were 
used for the analysis of the data that will be gathered from participants. In Chapter 4 




Chapter 4: Results 
The purpose of this quantitative investigation was to examine factors related to 
adherence to diabetes medication among individuals with type 2 diabetes in Cambridge, 
Canada. The variables assessed for their association with adherence to diabetes 
medication in the current study included age, gender, level of education, and diabetes 
knowledge. These independent factors may predict an association to adherence to type 2 
diabetes medication (the dependent variable) among individuals with type 2 diabetes in 
Cambridge. The research questions and hypotheses were as follows: 
RQ1: Are age, gender, diabetes knowledge, and level of education associated 
with adherence to diabetes medication among individuals with type 2 
diabetes in Cambridge? 
Ho1: There is no relationship between age and adherence to diabetes 
medications among individuals with type 2 diabetes in Cambridge. 
Ha1: There is a relationship between age and adherence to diabetes medications 
among individuals with type 2 diabetes in Cambridge. 
Ho2: There is no relationship between gender and adherence to diabetes 
medications among individuals type 2 with diabetes in Cambridge. 
Ha2: There is a relationship between gender and adherence to diabetes 
medications among individuals with type 2 diabetes in Cambridge. 
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H03: There is no relationship between level of education and adherence to 
diabetes medications among individuals with type 2 diabetes in 
Cambridge. 
Ha3: There is a relationship between level of education and adherence to 
diabetes medications among individuals with type 2 diabetes in 
Cambridge. 
H04: There is no relationship between diabetes knowledge and adherence to 
diabetes medications among individuals with type 2 diabetes in 
Cambridge. 
Ha4: There is a relationship between diabetes knowledge and adherence to 
diabetes medications among individuals with type 2 diabetes in 
Cambridge. 
RQ2: Are any pair-wise combinations of the variables age, gender, diabetes 
knowledge, and level of education associated with adherence to diabetes 
medication among individuals with type 2 diabetes in Cambridge? 
Ho5: The age and gender combination is not significantly linked to adherence to 
diabetes medications among people with type 2 diabetes in Cambridge. 
Ha5: The age and gender combination is significantly linked to adherence to 
diabetes medication among individuals with type 2 diabetes in Cambridge. 
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Ho6: The age and level of education combination is not significantly linked to 
adherence to diabetes medication among individuals with type 2 diabetes 
in Cambridge. 
Ha6: The age and level of education combination is significantly linked to 
adherence diabetes medication among individuals with type 2 diabetes in 
Cambridge 
Ho7: The age and diabetes knowledge combination is not significantly linked to 
adherence to diabetes medication among individuals with type 2 diabetes 
in Cambridge. 
Ha7: The age and diabetes knowledge combination is significantly linked to 
adherence to diabetes medication among individuals with type 2 diabetes 
in Cambridge. 
Ho8: The gender and level of education combination is not significantly linked 
to adherence to diabetes medication among individuals with type 2 
diabetes in Cambridge 
Ha8: The gender and level of education combination is significantly linked to 
adherence to diabetes medication among individuals with type 2 diabetes 
in Cambridge. 
Ho9: The gender and diabetes knowledge combination is not significantly 
linked to adherence to diabetes medication among individuals with type 2 
diabetes in Cambridge. 
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Ha9: The gender and diabetes knowledge combination is not significantly 
linked to adherence to diabetes medication among individuals with type 2 
diabetes in Cambridge. 
Ho10: The level of education and diabetes knowledge combination is not 
significantly linked to adherence to diabetes medication among individuals 
with type 2 diabetes in Cambridge. 
Ha10: The level of education and diabetes knowledge combination is 
significantly linked to adherence to diabetes medication among individuals 
with type 2 diabetes in Cambridge. 
Chapter 4 is divided into three subsections. The introduction contains a brief 
summary of research purpose, questions, and hypotheses. The result section contains 
reports of descriptive and inferential statistical analysis. The results are organized by the 
research questions and hypothesis. Figures and tables are also included in the result 
subsection. 
Data Analysis 
Descriptive statistical analysis was employed to describe participant 
demographics and study variables. Percentages and frequency were computed for age, 
gender, level of education and diabetes knowledge. Binary logistic regression analysis 
was conducted for each independent variable and the dependent variable to identify 
whether there was an association between the predictor variable and the response 
variable. Multiple logistic analyses were conducted to determine whether any 
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combination of predictors was associated with adherence to diabetes medication among 
Cambridge residents with type 2 diabetes. 
Results 
A total of 56 individuals met criteria for participation in the research, signed the 
consent form, and correctly completed the questionnaire. Of the study participants who 
successfully completed the questionnaires, two (3.6%) were aged 35–44 years, nine 
(16.1%) were aged 45–54 years, 16 (28.6%) were aged 55–64 years, and 28 (51.8%) 
were aged 65 years and over. Data on the gender of participants indicated that 36 (64.3%) 
were male and 20 (35.7%) were female. All participants indicated that they lived in 
Cambridge. The mean age of study participants was 50.97 years. Additionally, 23 
(41.1%) of the participants reported that they had an elementary-level education, 15 
(26.8%) reported that they had a high school education, 9 (16.1%) indicated that they had 
a college education, and 9 (16.1%) indicated that they had graduated from a university. 







Frequency Distribution of Sociodemographic Characteristics of Study Sample  
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Note: N = 56. 
Data on participants’ diabetes knowledge indicated that 49(87.5%) participants 
displayed adequate or satisfactory knowledge of diabetes while 7(12.5%) participants had 
inadequate or poor knowledge of diabetes. The Michigan Diabetes Knowledge Test 
instrument was used for diabetes knowledge evaluation. A total score ≥ 7 was rated as 
good diabetes knowledge, whereas a total score <7 was rated as poor knowledge. Table 2 




Frequency Distribution of Participants Diabetes Knowledge 
 
  Diabetes knowledge 
Variable n Poor knowledge 
n = 7 
Good knowledge 
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Note: N = 56. 
The levels of adherence of there search participants were as follows. Of the 56 
study participants, 15 (26.8 %) reported poor adherence (adherence total scores of < 6 on 
the MMAS), and 41 (73.2%) reported good adherence (total adherence scores of ≥ 6 on 
the MMAS). The nonadherence rate of about 27% indicates that nonadherence is a 
problem among diabetes patients in Cambridge. Table 3 summarizes the frequency 




Frequency Distribution of Participants’ Adherence Level  
 
  Medication adherence 
Variable n Poor adherence 
n = 15 
Good adherence 
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Note: N = 56. 
Table 4 shows the results of testing multicollinearity in the study data. The 
findings show that the variance inflation factor (VIF) value of each the independent 
variables was within the limit, which was above 1.00 (Field, 2009; Myers, 1990). The 
tolerance value of each predictor variable was noted to be more than 0.2, and as result, 





Collinearity Matrix of Independent Variables  
 
  Collinearity statistics 
Variable Significance Tolerance VIF 
Age .769 .973 1.028 
Gender .944 .956 1.046 
Level of education .011 .923 1.083 
Diabetes knowledge .018 .917 1.091 
Note: N = 56. 
Hypothesis Testing 
Research Question 1 
Research Question 1 was as follows: Are the variables of age, gender, diabetes 
knowledge, and level of education associated with adherence to diabetes among 
individuals with type 2 diabetes in Cambridge? 
The first hypothesis tested in this study was related to age and adherence to type 2 
diabetes medications. The first hypothesis states that there is no relationship between age 
and adherence to type 2 diabetes medications among individuals with type 2 diabetes in 
Cambridge. To determine the correlation between age and adherence to type 2 diabetes 
medications, a binary logistic regression analysis was conducted. The dependent variable 
(adherence to diabetes medication) was measured on a categorical scale, and coded as 1 = 
poor adherence (total score on the MMAS <6) and 2 = good adherence(total score on the 
MMAS ≥6). Age (independent variable) was categorized into groups and assigned the 
value of 0, 1, 2, or 3 to represent age groups 35–44, 45–54, 55–64, and 65 and over, 
respectively. For the age group 35 to 44 years, all (100%) participants were good 
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adherents to type 2 diabetes medications (n = 2; 3.6%). Participants in the age group of 
45 to 54 had an adherence rate of 77.8% and a nonadherence rate of 22.2% to type 2 
diabetes medications (n = 9; 16.1%). Patients in the55 to 64 age group showed adherence 
of 68.8% and nonadherence of 31.2% to their diabetes medications (n = 16; 28.6%). In 
the age group of 65 years and over, 72.4% of patients adhered to their diabetes 
medications and 27.6% were nonadherent (n = 29; 51.8%). Table 5 shows the results of 
the binary logistic analysis of age and adherence to diabetes medication .The odds ratio 
for the association between age and adherence to type 2 diabetes medications among 
individuals living with diabetes in Cambridge was calculated to 0.801 with a p-value of 
0.549. Because the p-value calculated is greater than 0.05, the null hypothesis is not 
rejected. Therefore, there is no association between age and adherence to medications 
among individuals with type 2 diabetes in Cambridge . 
The second hypothesis tested in this study was related to gender and adherence to 
type 2 diabetes medications which states that there is no relationship between gender and 
adherence to diabetes medications among individuals with type 2 diabetes in Cambridge. 
To examine this hypothesis, a binary regression analysis was performed. In this statistical 
analysis, adherence to diabetes medications (dependent variable) was measured on a 
categorical scale and coded 1 =poor adherence (total score on the MMAS is less than 6) 
and 2 = good adherence (total score on the MMAS is 6 and above). Gender was coded as 
0 = male and 1 = female. The adherence rate for females was 75% and nonadherence rate 
was 25% (n = 20; 35.71%) while the males showed an adherence rate of 72.2% and a 
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nonadherence rate of 27.8% (n = 36; 64.28%.). Table 5 shows the results of the binary 
logistic regression. The odds ratio in the relationship of gender and adherence to type 2 
diabetes medications was calculated to 1.154 with a p-value of 0.821. The calculated p-
value is greater than 0.05. Therefore, we fail reject the null hypothesis. Accepting the null 
hypothesis indicates that there is no association between gender and adherence to 
diabetes medication among individuals with type 2 diabetes in Cambridge. 
The third hypothesis tested in this study was related to level of education and 
adherence to type 2 diabetes medications. The third hypothesis states there is no 
relationship between level of education and adherence to medications among individuals 
with type 2 diabetes in Cambridge. To determine a correlation between level of education 
and adherence to type 2 diabetes medication, a binary logistic regression analysis was 
done. The dependent variable (adherence to diabetes medications) was given the value of 
1 = poor adherence (total score on the MMAS is less than 6); and 2 = good adherence 
(total score on the MMAS is less 6 and above). Level of education (independent variable) 
was also given the value of 1, 2, 3, 4 to represent elementary school, high school, college 
and university respectively. Table 5 describes the results of the correlation analysis of 
level of education and adherence using binary logistic regression analysis. The result 
shows that the odds ratio of the association between level of education and adherence to 
type 2 diabetes medications was calculated to 3.473 with a p-value of 0.001. Since the p-
value calculated is less than 0.05, the null hypothesis was rejected. Rejection of the null 
hypothesis suggest that there is significant statistical association between level of 
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education and adherence to diabetes medications among Cambridge residents with type 2 
diabetes 
The fourth hypothesis tested in this study was related to diabetes knowledge and 
adherence to type 2 diabetes medications. The fourth hypothesis states there is no 
relationship between diabetes knowledge and adherence to diabetes medications among 
individuals with diabetes in Cambridge. To determine a correlation between diabetes 
knowledge and adherence to diabetes medication, a binary logistic regression analysis 
was conducted. Adherence to diabetes medications (dependent variable) was measured 
on a categorical scale, and coded as 1 = poor adherence; 2= good adherence. Diabetes 
knowledge was also categorized into good and poor diabetes knowledge. Diabetes 
knowledge was coded as 0 = good diabetes knowledge (total score on the Michigan 
Diabetes Knowledge Scale is 7 and above; 1 = poor diabetes knowledge (Total score on 
the Michigan diabetes knowledge scale is less than 7). Table 5 describes the results of the 
binary logistic regression analysis of diabetes knowledge and adherence to diabetes 
medication. The odds ratio for the association between diabetes knowledge and 
adherence to type 2 diabetes medications among individual with diabetes in Cambridge 
was calculated to 0.103 with a p-value of 0.008. Although the p-value calculated is less 
than 0.05, since the odd ratio is less than 1, the null hypothesis was not rejected. There is 
therefore no association between diabetes knowledge and adherence to medications 




Binary Logistic Regression Omnibus Test Results of the Analysis of the Relationship 
Between Independent Variables and the Dependent Variable Using SPSS 
 
  95% Confidence interval  p-value 
Variable OR  Lower Upper  
Age & adherence .801 .388 1.654 .549 
Gender & adherence 1.154 .331 4.017 .821 
Level of education & 
adherence 
3.373 1.338 8.691 .001* 
Diabetes knowledge & 
adherence 
.103 .017 .609 .008* 
Note: N = 56. Odds ratios were calculated using a 95% confidence interval. An alpha level of 0.05 was 
used.*Shows a strong association to adherence to medications among individual with type 2 diabetes in 
Cambridge. 
Research Question 2 
Research Question 2 
Research Question 2 was as follows: Is there a group of factors that are linked to 
adherence to diabetes management among individuals with diabetes in Cambridge? 
The fifth hypothesis tested related to age, gender and adherence to diabetes 
medication. The fifth hypothesis states that there is no associated between the 
combination of age, gender and adherence to diabetes medication among individuals with 
type 2 diabetes in Cambridge. The result of the multiple regression analysis of age, 
gender and adherence to type 2 diabetes medication is shown in Table 6. The analysis 
produced an odd ratio value of 0.805 for age, 1.124 for gender and a p-value of 0.816. 
Since the P-value is higher than 0.05, the null hypothesis was accepted. The combination 
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of age and gender is therefore, not a predictor of adherence to diabetes medications 
among individual with type 2 diabetes in Cambridge. 
The sixth hypothesis tested related to age, level of education and adherence to 
diabetes medication. The sixth hypothesis states that there is no associated between the 
combination of age, level of education and adherence to diabetes medication among 
individuals with type 2 diabetes in Cambridge. Results in Table 6 shows that the 
combination of age and level of level education is a strong predictor of adherence to type 
2 diabetes medications among individuals with type 2 diabetes in Cambridge. The 
analysis result shows that, the age odds ratio was calculated as 0.975 and odd ratio for 
level of education is 3.454 with a p-value of 0.003. Since the P-value is smaller than 
0.05, the null hypothesis was rejected. Therefore, the combination of age and level of 
education was a predictor of adherence to diabetes type 2 medications among individuals 
with type 2 diabetes in Cambridge. 
The seventh hypothesis states that there is no association between combination of 
age, diabetes knowledge and adherence to type 2 diabetes medications. As shown in 
Table 6, the odds ratio for the combination of age and diabetes knowledge was calculated 
as 0.770 for age and 0.100 for diabetes knowledge with a p-value 0.023. Since the P-
value is smaller than 0.05, the null hypothesis was rejected. Therefore the combination of 
age and diabetes knowledge was a significant predictor of adherence to diabetes 
medications among Cambridge residents with type 2 diabetes. 
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The combination of gender and level of education is a strong predictor of 
adherence to diabetes medications among individuals living in Cambridge with type 2 
diabetes. As reported in Table 6, the odds ratio calculated for gender is 1.224 and 3.465 
for level of education with a p-value of 0.003. Since the p-value is smaller than 0.05, the 
null hypothesis was rejected. There is therefore a significant statistical relationship 
between the combination of gender, level of education and adherence to medications 
among individuals with diabetes type 2 diabetes in Cambridge. 
The combination of gender and diabetes education is a strong predictor of 
adherence to type 2 diabetes medications among Cambridge residents with type 2 
diabetes. As shown in Table 6, the odds ratio calculated for gender is .822 and 0.097 for 
diabetes knowledge with a p-value of 0.027. Since the calculated p-value is smaller than 
the significant p-value of 0.05, we reject the null hypothesis. Therefore, there is an 
association between the combination of gender, diabetes education, and adherence to type 
2 diabetes medications among individuals residing in Cambridge with type 2 diabetes. 
The combination of level of education and diabetes knowledge is a significant, 
strong predictor of adherence to diabetes medications among individuals living in 
Cambridge with type 2 diabetes. As reported in the Table 6, the odds ratio calculated for 
level of education is 3.198 and 0.140 for diabetes knowledge with a p-value of 0.000. 
Since the computed p-value for the combination is smaller than the significant p-value of 
0.05, the null hypothesis was rejected, indicating that there is a statistical significant 
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relationship between the combination of level of education, diabetes knowledge and 
adherence to medications among individuals with diabetes type 2 diabetes in Cambridge.  
Table 6 
Multivariate Omnibus Test Results of the Analysis of Association of the Combination of 
Two Different Independent Variables and Adherence to Diabetes Medication  
 
   95% Confidence interval  p-value 
Variable OR  B Lower Upper  







































































Note: N = 57. Odds ratios were calculated using a 95% confidence interval. An alpha level of 0.05 was 
used.*Shows a strong association to adherence to medications among individual with type 2 diabetes in 
Cambridge. 
The result of the multiple regression analysis of the association of the 
combination of all the independent variables (age, gender, level of education and diabetes 






Multivariate Omnibus Test Results for the Association of the Combination of All the 
Independent Variables and Adherence to Diabetes Medication Using SPSS 
 
   95% Confidence interval  p-value 
Variable OR  B Lower Upper  
Age -.067 .935 .395 2.297 .880 
Gender -.093 .991 .209 3.97 .901 
Level of education 1.147 3.148 1.210 8.192 .019* 
Diabetes knowledge -2.006 .135 .018 1.003 .050 
Constant 1.509 5.521   .436 
Note: N = 56. Odds ratios were calculated using a 95% confidence interval. An alpha level of 0.05 was 
used.*Shows a strong association to adherence to medications among individual with type 2 diabetes in 
Cambridge. 
Summary 
There was a statistically significant association between adherence to type 2 
diabetes medications and level of education. In addition, the following combined 
variables; age and level of education; age and diabetes knowledge; gender and level of 
education; gender and diabetes knowledge; level of education and diabetes knowledge 
were noted to be significantly associated with adherence to type 2 diabetes medications. 
In Chapter 5 interpretations of the results, limitations of the research, recommendations 




Chapter 5: Discussion, Conclusions, and Recommendations 
The purpose of this research was to investigate whether age, gender, level of 
education or diabetes knowledge predict adherence to type 2 diabetes medication among 
diabetes patients in Cambridge, Canada. The study is aimed at motivating and assisting 
Cambridge residence with type 2 diabetes to adhere to their diabetes medication 
regimens. The research sample consisted of 56 Cambridge residents who got their 
diabetes medication from Metro pharmacy in Cambridge. All study participants indicated 
that they had been diagnosed with type 2 diabetes and were taking diabetes medication 
regimens. Suboptimal adherence to the use of diabetes medication can result in high 
mortality and morbidity in individuals with type 2 diabetes (Nagelkerk et al., 2006). The 
prevalence and incidence of type 2 diabetes are on the rise in Canada (Canadian Diabetes 
Association, 2013; Public Health Agency of Canada, 2011) and the fact that no adherence 
study have ever been conducted among individuals with type 2 diabetes in Cambridge, it 
was necessary to focus on Cambridge residents with diabetes and address the research 
questions. 
Patients’ demographic data were collected using the WHO STEPS demographic 
instrument, diabetes knowledge was assessed with the Michigan Diabetes Knowledge 
Scale while medication adherence was measured with the MMAS. Binary and multiple 
logistic regression analyses were employed to analyze the data and test the hypotheses. 
The effects of all of the variables used in this study were explored using the overall 
model of omnibus test of coefficient or overall model significance. The omnibus test of 
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model coefficient table shows chi-square results that indicate whether there is a 
significant relationship between the dependent and the independent variables. Some of 
the findings were significant whereas others were not. The TPB was employed as the 
theoretical framework for this research 
Interpretation of Findings 
Finding 1: Age and Adherence 
I discovered that there was no relationship between age and adherence to type 2 
diabetes medications among Cambridge residents with diabetes. The adherence rate 
among participants in this study was 73.2%, compared to 26.8% nonadherence. For the 
age group 35 to 44 years, 100% of participants were good adherers to their type 2 
diabetes medications (n = 2; 3.6%). Participants in the 45 to 54 group had an adherence 
rate of 77.8% and a nonadherence rate of 22.2% to type 2 diabetes medications (n = 9; 
16.1%). Patients in the 55 to 64 group showed adherence of 68.8% and nonadherence of 
31.2% (n = 16; 28.6%). In the 65 years of age and over group, 72.4% of patients adhered 
to their diabetes medications and 27.6% were nonadherent(n = 29; 51.8%). The statistical 
analysis results of the combined test model clearly showed that there is no statistically 
significant relationship between age and adherence to type2 diabetes medications among 
individuals with type 2 diabetes in Cambridge. The overall omnibus test of model 
coefficients yielded the following: chi-square = .373, p = .549, and OR = .801. The 
overall omnibus test of model coefficient odds ratio was .373, and the p-value was .549. 
There is therefore no association between age and adherence to type 2 diabetes 
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medications among individuals with type 2 diabetes in Cambridge. This finding is in 
concord with other studies that have reported that a patient’s age is not a predictor of 
adherence to diabetes medications (Khan et al., 2012; Nozaki et al., 2009). However, the 
results of this study are in disagreement with other studies that have shown that age is a 
strong determinant of adherence to diabetes medications (Cramer, 2004; Garcia-Perez et 
al., 2013). 
Finding 2: Gender and Adherence 
There was no association between gender and adherence to type 2 diabetes 
medications among individuals with diabetes in Cambridge. The overall omnibus test of 
model coefficients for sex generated the following results: chi-square = 0.051, p = 0.822, 
OR = 1.154.The results of this study are in agreement with those of a study conducted in 
Uganda (Bagonza et al., 2015) and contrast with the findings of an adherence study 
conducted in Saudi Arabia (Khan, 2012). I also found that adherence was lower for male 
participants than for female participants. The adherence rate for females was 75%, 
compared to nonadherence of 25% (n = 20; 35.71%); males hadean adherence rate of 
72.2% and a nonadherence rate of 27.8% (n = 36; 64.28 %).This result is in contrast to 
the result of an adherence study from the United Arab Emirates (Manjusha, 2014) that 
reported that men are better adherers than women. However, the findings in the present 
study are supported by previous studies conducted in Ethiopia and Germany (Gelaw et 
al., 2014; Raum et al., 2012). Regarding findings from this research, it may be 
worthwhile to conduct research into ways of encouraging male diabetes patients in 
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Cambridge to always seek medical attention when needed. Motivation can be increased 
through local campaigns and public announcements. 
Finding 3: Level of Education and Adherence 
I found that there was a significant relationship between level of education and 
adherence to type 2 diabetes medications among type 2 diabetes patients in Cambridge. 
The overall omnibus test of model coefficients for level of education yielded the 
following results: chi-square = 11.362; p = .008; OR 3= .473. The overall study 
adherence rate for study participants was 73.2%, and the medication nonadherence rate 
was 26.8%. Patients with only elementary education showed an adherence rate of 47.82% 
and a nonadherence rate of 42.18% (n = 23; 41.07%). Participants with high school 
education showed an adherence rate of 93.35% and a nonadherence rate of 6.65% (n = 
15; 79%). The adherence rate for volunteers with a college education was 77.77%, 
compared to a nonadherence rate of 22.23 % (n = 9; 16.07%). Patients with university 
degrees showed a 100% adherence rate and a 0% nonadherence rate (n = 9; 16.07%). The 
result of this study contrasts with a study conducted in Uganda (Bagonza et al., 2015). 
However the findings in this study are in agreement with other studies that reported that 
level of education is significantly associated with adherence to type 2 diabetes medication 
(Gelaw et al., 2014; Khan et al., 2012). Based on the findings from this study, level of 
education may be investigated as a predictor variable in future adherence studies. 
121 
 
Finding 4: Diabetes Knowledge and Adherence 
The results of the bivariate analysis of the association between diabetes 
knowledge and adherence to type2 diabetes medication among patients with type 2 
diabetes shows that there is no significant relationship between diabetes knowledge and 
adherence to diabetes medications. The omnibus test of model coefficients for diabetes 
knowledge yielded the following overall results: chi-square = 7,120, p = .012, OR 
=0.103. Crosstab results show that 79.59% of study participants had good knowledge of 
diabetes, whereas 22.41% of the participants displayed poor diabetes knowledge. The 
results of this study are in disagreement with the results of the study conducted in 
Palestine by Sweileh et al. (2014), which indicated that diabetes knowledge is associated 
with adherence to diabetes medication. Based on the findings from this study, diabetes 
knowledge may be investigated as a predictor variable in future adherence studies. It may 
be more beneficial to tailor diabetes knowledge education classes to meet individual 
patient needs and circumstances. Some of the circumstances that need to be considered in 
designing diabetes education include participants’ limited education, language barriers, 
and limited diabetes knowledge. Diabetes patients should always be encouraged to come 
to diabetes education classes with their family members. These relatives can assist them 
in better understanding the lessons that are taught to them in their diabetes education 
classes. Patient education is one of the most effective ways of managing diabetes and 
reducing complications (Mulcahy et al., 2011). WHO (2003) stated that health education 
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is beneficial to patients and that diabetes or health educators should stick to similar 
teaching protocols that will assist patient adhere to their diabetes management plan. 
Finding 5: Age, Gender, and Adherence 
The combination of age and gender was not noted to be a strong predictor of 
adherence to type 2 diabetes medications among diabetes patients in Cambridge using the 
alpha p-value of 0.05. The omnibus tests of model coefficients yielded the following 
overall results: chi-square =.407, p = 0.816, OR =.805/1.124. This finding clearly shows 
that the combination of sociodemographic factors such as age and gender is not 
associated with adherence. In this regard, this study is in agreement with another study 
conducted in Uganda (Bagonza et al., 2015). However, a study conducted in Saudi 
Arabia reported that age and gender were associated with adherence to diabetes 
medication (Salam & Siddiqui, 2013). Findings from this research may assist 
investigators in deciding the usefulness of age and gender in future adherence studies. 
Finding 6: Age, Level of Education, and Adherence 
The combination of age and level of education was noted to be a strong predictor 
of adherence to type 2 diabetes medications among diabetes patients in Cambridge. The 
results of the overall logistic regression omnibus tests of model coefficients were as 
follows: chi-square =11.366, p = .003, OR = 0.975/3.454. When age and diabetes 
knowledge were analyzed separately with the dependent variable, the result showed that 
age was not associated with adherence while diabetes knowledge was noted to be 
associated with adherence to type 2 diabetes medication. Surprisingly, when the 
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combination of age and gender was analyzed with adherence to diabetes medication in a 
multivariate analysis, the combination was noted to be a strong predictor of adherence to 
diabetes medication. Research on the association between adherence to type 2 diabetes 
medications and the combination of age and level of education has never been conducted 
in Cambridge. Therefore, the results of this research may be useful for future 
investigations involving the combinations of variables used in this study. 
Finding 7: Age, Diabetes Knowledge, and Adherence 
The combination of age and diabetes education was a good predictor of adherence 
to diabetes medications among type 2 diabetes patients in Cambridge. When age was 
analyzed with adherence to diabetes medication in a binary logistic regression analysis, 
age was noted to be a poor predictor of adherence. However, when the combination of 
age and diabetes knowledge was analyzed with adherence in a multiple logistic 
regression analysis, the combination was noted to be a strong predictor of adherence to 
diabetes medication. The overall result of the logistic regression omnibus test of model 
coefficients was as follows: chi-square = 7.559, p = .023, OR =770/.100. It is important to 
educate diabetes patients of all ages about diabetes and adherence to diabetes medication. 
Good diabetes knowledge is related to better adherence to diabetes medication. 
Finding 8: Gender, Level of Education, and Adherence 
The combination of gender and level of education was noted to be a strong 
predictor of adherence to type 2 diabetes medications among diabetes patients in 
Cambridge using the alpha p-value of 0.05. The omnibus tests of model coefficients 
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yielded the following overall results: chi-square = 11.447; p =0.003; OR = 1.224/3.465. 
When these two predictor variables (gender and level of education) were analyzed 
individually with the dependent variable, the result showed that gender was not a strong 
predictor of adherence while level of education was noted to be associated with 
adherence to type 2 diabetes. Interestingly, the combination of gender and level of 
education was noted to be a strong predictor of adherence to diabetes medication. Since 
the association of adherence to type 2 diabetes and the combination of gender and level 
of education have never been previously studied, future study is needed to explore 
whether gender combined with level of education is a predictor of medication adherence 
among type 2 diabetes patients in Cambridge. 
Finding 9: Gender, Diabetes Knowledge and Adherence 
There is an association between the combination of gender, diabetes knowledge 
and adherence. The combination of gender and diabetes knowledge was noted to be 
strong in predicting adherence to type 2 diabetes medications among diabetes patients in 
Cambridge using the alpha p-value of 0.05. The overall omnibus tests of model 
coefficients produced the following results: chi-square =7.201, p = 0.027, OR = 
.822/.097. When these two predictor variables (gender and diabetes knowledge) were 
analyzed individually with the dependent variable, the result showed that gender was not 
a strong predictor of adherence and that diabetes knowledge was not statistically 
associated with adherence to type 2 diabetes. Unpredictably, the combination of gender 
and diabetes knowledge was noted to be a strong predictor of adherence to diabetes 
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medication. Because the association of adherence to type 2 diabetes and the combination 
of age and gender have not been previously studied, future study is needed to explore 
whether gender combined with diabetes knowledge is a predictor of medication 
adherence among type 2 diabetes patients in Cambridge. 
Finding 10: Level of Education, Diabetes Knowledge and Adherence 
There is an association between the combination of level of education and 
diabetes knowledge and adherence. The combination of level of education and diabetes 
knowledge was noted to be a strong predictor of adherence to type 2 diabetes medications 
among diabetes patients in Cambridge using the alpha p-value of 0.05.The overall 
omnibus tests of model coefficients produced the following results: chi-square = 15.804, 
p = 0.000; OR = 3.198/.140. When these two predictor variables were analyzed 
individually with the dependent variable, the result showed that level of education was 
significantly associated with adherence while diabetes knowledge was not statistically 
associated with adherence among type 2 diabetes patients in Cambridge. It is therefore 
surprising that the combination of level of education and diabetes knowledge was a 
strong predictor of adherence to diabetes medication. Consequently, this result indicates 
that intervention that employs an integrative approach might be useful for addressing the 
adherence issue among individuals with diabetes in Cambridge. In that the association of 
adherence to type 2 diabetes medication and the combination of level of education and 
diabetes knowledge have not been previously studied in Cambridge, future study is 
needed to explore whether level of education combined with diabetes knowledge is a 
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predictor of medication adherence among type 2 diabetes patients in Cambridge. 
Moreover, in the fully adjusted model in which adherence was assessed as a function of 
each of the following—age, gender, level of education, and diabetes knowledge—only 
level of education showed a statistically significant relationship with adherence, as shown 
in Table 3. Further, the multiple logistic analysis of the combination of all of the 
variables with adherence also showed that only level of education significantly associated 
with adherence, as shown in Table 7. This suggests that intervention that focuses on 
helping diabetes patients, especially those with low levels of education, to fully 
understand the benefits of adherence to medication can help in improving adherence to 
diabetes medications. 
Recommendations 
The research results show that only level of education is strong predictors of 
adherence to type 2 diabetes medications among diabetes patients in Cambridge. 
Consequently, further research is required to identify other possible predictors. The 
development of diabetes knowledge through education is known to have a role in 
diabetes management, in that it builds required skills and empowers patients to take up 
everyday responsibilities to manage their disease condition (Khunti et al., 2008). It is the 
duty of clinicians to organize and teach personalized diabetes education classes. 
However, it is also the duty of patients to attend diabetes education classes. WHO (2003) 
stated that health education is for beneficial to patients and that health or diabetes 
educators should stick to similar teaching protocols that will assist adhere to their 
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diabetes management plan. Diabetes clinics, hospitals, and diabetes educators and 
physicians must stick to similar protocols for educating patients about diet, foot care, 
alcoholic beverage consumption, exercise, medication adherence, and the effects that 
these have on diabetes management and the onset of diabetes complications. Diabetes 
education can assist in increasing patients ‘awareness about self-management and 
medication adherence. Furthermore, future researchers may consider the effects of 
variables such as income and family size on adherence to type 2 diabetes medications. 
Symptoms of diabetes generally become obvious to patients when their blood sugar 
levels are well above normal. Therefore, healthcare professionals should encourage 
patients to engage in regular glucose testing, so that patients can see the need to adhere to 
their medications, engage in prescribed exercise, and follow a recommended diet. In 
addition, because diabetes knowledge is a modifiable factor, physicians and other 
clinicians involved in diabetes care should be encouraged to always give clear, high-
quality information about diabetes and diabetes medications. Diabetes information should 
always be communicated in a manner that will help patients become more aware of 
potential future complications of diabetes and the benefits of adhering to drug therapy. 
This research was a small cross-sectional study; future large-scale research is required for 




Limitations of the Study 
This research study is limited to only patients diagnosed of type 2 diabetes and 
lived in Cambridge. Members of the population with type 2 diabetes that indicated their 
intention to be part of this study were very limited and as a result I used convenient 
sampling method because it affords me the opportunity to collect data from population 
members that were conveniently available. Also convenient sampling method enabled me 
to realize the sample size that I could achieve in a relatively fast and inexpensive way. As 
a result of the use of convenience sampling method for study participants recruitment, 
this research is limited to type 2 diabetes patients in Cambridge and should not be 
generalize beyond similar population with type 2 diabetes. The sample size used for this 
study was small and it is possible that a larger number of participants than the one used in 
this research may have produced outcomes different from the ones reported in this study. 
Larger sample size may cover a broader geographical area, and may have more 
diversified population than the one used in this research. This study was correlational in 
nature and as a result, the focus was on the association between factors (independent 
variables) that influence adherence to diabetes medications (dependent variable) and as a 
result causation was not assessed. Future investigators may contemplate using another 
population to explore and clarify factors that are associated with adherence to type 2 
diabetes. Finally, study participants’ adherence to diabetes medications were based on 
self-assessment reports that were not observed nor examined; thus, their actual adherence 
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to diabetes medication may be overestimated and may have some biases that could not be 
verified. 
Implications for Social Change 
Swan (2010) stated that assisting diabetes patients to understand their barriers to 
managing their diabetic condition is paramount to preventing the barriers. Knowing the 
reason why diabetes patients are not able to take their medication as prescribed is 
essential for the individual patient, their family and healthcare providers. Reducing cost 
and diabetes-related complications and improving the quality of life of patients is 
important to all stockholders: financiers of healthcare for those without insurance, 
insurance payers, the government, health professionals, patients, and their families. A 
good knowledge of diabetes and optimal adherences to prescribed medications by 
patients with type 2 diabetes in Cambridge will help decrease complications such as 
retinopathy, kidney disease, peripheral neuropathy, coronary and artery disease. 
Adherence to diabetes medications help improves well-being, preserves body image and 
prevents premature deaths. In addition, adherence to diabetes medications help improves 
patients’ psychological well-being, encourages and empowers patient to self-manage 
their diabetes condition. The findings of this study research could aid in implementing 
national policies in relation to adherence to diabetes medication in Canada for individual 
with type 2 diabetes. Diabetes education through video or reading materials should be 
provided in physicians and pharmacy waiting rooms. Adequate Incentives such as 
coupons, free diabetic needles and strips should be offered to patients as a way of 
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encouraging them to attend diabetes education classes. Funds through grants from 
stakeholder should be made available for the promotion of diabetes education through the 
mass media on a regular basis. 
Conclusion 
In this study, assessment of the factors that influence adherence to type 2 diabetes 
medications was conducted in a cross-sectional setting. While a good number of 
individuals with type 2 diabetes in Cambridge engage in medication adherence behaviors, 
knowing and understanding factors that impact adherence to diabetes medication can help 
in the creation and utilization of the right intervention program that will create positive 
behavior change in patient. Analysis of the association between adherence to diabetes 
medication and each of the following; age, gender, level of education and diabetes 
knowledge shows that only level of education influences adherence to diabetes 
medication. The result of this study shows that type 2 diabetes patient with higher levels 
of education adhere better to their medication compare to those with lower levels of 
education. Intervention that focuses on helping diabetes patient especially those with low 
level of education to fully understand the benefit of adherence to medication can help in 
improving adherence to diabetes medication and prevention of diabetes-related 
complications. Good adherence promotes better quality of life which consequently 
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